(1) Bliek, A. M. van der; Sedensky, M. M.; Morgan, P. G. Cell Biology of the Mitochondrion. Genetics 2017, 207 (3), 843–871. https://doi.org/10.1534/genetics.117.300262.
(2) Zhu, X.-H.; Qiao, H.; Du, F.; Xiong, Q.; Liu, X.; Zhang, X.; Ugurbil, K.; Chen, W. Quantitative Imaging of Energy Expenditure in Human Brain. Neuroimage 2012, 60 (4), 2107–2117. https://doi.org/10.1016/j.neuroimage.2012.02.013.
(3) Pérez-Treviño, P.; Velásquez, M.; García, N. Mechanisms of Mitochondrial DNA Escape and Its Relationship with Different Metabolic Diseases. Biochim Biophys Acta Mol Basis Dis 2020, 1866 (6), 165761. https://doi.org/10.1016/j.bbadis.2020.165761.
(4) Chen, Y.; Lin, J.-R.; Gao, P.-J. Mitochondrial Division Inhibitor Mdivi-1 Ameliorates Angiotensin II-Induced Endothelial Dysfunction. Sheng Li Xue Bao 2016, 68 (5), 669–676.
(5) Ballinger, S. W.; Patterson, C.; Yan, C. N.; Doan, R.; Burow, D. L.; Young, C. G.; Yakes, F. M.; Van Houten, B.; Ballinger, C. A.; Freeman, B. A.; Runge, M. S. Hydrogen Peroxide- and Peroxynitrite-Induced Mitochondrial DNA Damage and Dysfunction in Vascular Endothelial and Smooth Muscle Cells. Circ. Res. 2000, 86 (9), 960–966. https://doi.org/10.1161/01.res.86.9.960.
(6) Ballinger, S. W.; Patterson, C.; Knight-Lozano, C. A.; Burow, D. L.; Conklin, C. A.; Hu, Z.; Reuf, J.; Horaist, C.; Lebovitz, R.; Hunter, G. C.; McIntyre, K.; Runge, M. S. Mitochondrial Integrity and Function in Atherogenesis. Circulation 2002, 106 (5), 544–549. https://doi.org/10.1161/01.cir.0000023921.93743.89.
(7) Chen, J.; Mehta, J. L.; Haider, N.; Zhang, X.; Narula, J.; Li, D. Role of Caspases in Ox-LDL-Induced Apoptotic Cascade in Human Coronary Artery Endothelial Cells. Circ. Res. 2004, 94 (3), 370–376. https://doi.org/10.1161/01.RES.0000113782.07824.BE.
(8) Vindis, C.; Elbaz, M.; Escargueil-Blanc, I.; Augé, N.; Heniquez, A.; Thiers, J.-C.; Nègre-Salvayre, A.; Salvayre, R. Two Distinct Calcium-Dependent Mitochondrial Pathways Are Involved in Oxidized LDL-Induced Apoptosis. Arterioscler. Thromb. Vasc. Biol. 2005, 25 (3), 639–645. https://doi.org/10.1161/01.ATV.0000154359.60886.33.
(9) Yu, E.; Calvert, P. A.; Mercer, J. R.; Harrison, J.; Baker, L.; Figg, N. L.; Kumar, S.; Wang, J. C.; Hurst, L. A.; Obaid, D. R.; Logan, A.; West, N. E. J.; Clarke, M. C. H.; Vidal-Puig, A.; Murphy, M. P.; Bennett, M. R. Mitochondrial DNA Damage Can Promote Atherosclerosis Independently of Reactive Oxygen Species through Effects on Smooth Muscle Cells and Monocytes and Correlates with Higher-Risk Plaques in Humans. Circulation 2013, 128 (7), 702–712. https://doi.org/10.1161/CIRCULATIONAHA.113.002271.
(10) Grootaert, M. O. J.; Moulis, M.; Roth, L.; Martinet, W.; Vindis, C.; Bennett, M. R.; De Meyer, G. R. Y. Vascular Smooth Muscle Cell Death, Autophagy and Senescence in Atherosclerosis. Cardiovasc. Res. 2018, 114 (4), 622–634. https://doi.org/10.1093/cvr/cvy007.
(11) Paradies, G.; Petrosillo, G.; Pistolese, M.; Di Venosa, N.; Federici, A.; Ruggiero, F. M. Decrease in Mitochondrial Complex I Activity in Ischemic/Reperfused Rat Heart: Involvement of Reactive Oxygen Species and Cardiolipin. Circ. Res. 2004, 94 (1), 53–59. https://doi.org/10.1161/01.RES.0000109416.56608.64.
(12) Chen, Q.; Camara, A. K. S.; Stowe, D. F.; Hoppel, C. L.; Lesnefsky, E. J. Modulation of Electron Transport Protects Cardiac Mitochondria and Decreases Myocardial Injury during Ischemia and Reperfusion. Am. J. Physiol., Cell Physiol. 2007, 292 (1), C137-147. https://doi.org/10.1152/ajpcell.00270.2006.
(13) Wang, J.; Toan, S.; Zhou, H. New Insights into the Role of Mitochondria in Cardiac Microvascular Ischemia/Reperfusion Injury. Angiogenesis 2020. https://doi.org/10.1007/s10456-020-09720-2.
(14) Przyklenk, K.; Bauer, B.; Ovize, M.; Kloner, R. A.; Whittaker, P. Regional Ischemic “preconditioning” Protects Remote Virgin Myocardium from Subsequent Sustained Coronary Occlusion. Circulation 1993, 87 (3), 893–899. https://doi.org/10.1161/01.cir.87.3.893.
(15) Muntean, D. M.; Sturza, A.; Dănilă, M. D.; Borza, C.; Duicu, O. M.; Mornoș, C. The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies. Oxid Med Cell Longev 2016, 2016, 8254942. https://doi.org/10.1155/2016/8254942.
(16) Postnov, I. V. [The role of mitochondrial calcium overload and energy deficiency in pathogenesis of arterial hypertension]. Arkh. Patol. 2001, 63 (3), 3–10.
(17) Stefanadi, E.; Tousoulis, D.; Androulakis, E. S.; Papageorgiou, N.; Charakida, M.; Siasos, G.; Tsioufis, C.; Stefanadis, C. Inflammatory Markers in Essential Hypertension: Potential Clinical Implications. Curr Vasc Pharmacol 2010, 8 (4), 509–516. https://doi.org/10.2174/157016110791330870.
(18) Dikalov, S. I.; Ungvari, Z. Role of Mitochondrial Oxidative Stress in Hypertension. Am. J. Physiol. Heart Circ. Physiol. 2013, 305 (10), H1417-1427. https://doi.org/10.1152/ajpheart.00089.2013.
(19) Szendroedi, J.; Phielix, E.; Roden, M. The Role of Mitochondria in Insulin Resistance and Type 2 Diabetes Mellitus. Nat Rev Endocrinol 2011, 8 (2), 92–103. https://doi.org/10.1038/nrendo.2011.138.
(20) Montgomery, M. K.; Turner, N. Mitochondrial Dysfunction and Insulin Resistance: An Update. Endocr Connect 2014, 4 (1), R1–R15. https://doi.org/10.1530/EC-14-0092.
(21) Watanabe, T.; Saotome, M.; Nobuhara, M.; Sakamoto, A.; Urushida, T.; Katoh, H.; Satoh, H.; Funaki, M.; Hayashi, H. Roles of Mitochondrial Fragmentation and Reactive Oxygen Species in Mitochondrial Dysfunction and Myocardial Insulin Resistance. Exp. Cell Res. 2014, 323 (2), 314–325. https://doi.org/10.1016/j.yexcr.2014.02.027.
(22) Kapogiannis, D.; Mattson, M. P. Disrupted Energy Metabolism and Neuronal Circuit Dysfunction in Cognitive Impairment and Alzheimer’s Disease. Lancet Neurol 2011, 10 (2), 187–198. https://doi.org/10.1016/S1474-4422(10)70277-5.
(23) Wilkins, H. M.; Swerdlow, R. H. Amyloid Precursor Protein Processing and Bioenergetics. Brain Res. Bull. 2017, 133, 71–79. https://doi.org/10.1016/j.brainresbull.2016.08.009.
(24) Overk, C.; Masliah, E. Perspective on the Calcium Dyshomeostasis Hypothesis in the Pathogenesis of Selective Neuronal Degeneration in Animal Models of Alzheimer’s Disease. Alzheimers Dement 2017, 13 (2), 183–185. https://doi.org/10.1016/j.jalz.2017.01.005.
(25) Kulich, S. M.; Chu, C. T. Role of Reactive Oxygen Species in Extracellular Signal-Regulated Protein Kinase Phosphorylation and 6-Hydroxydopamine Cytotoxicity. J. Biosci. 2003, 28 (1), 83–89. https://doi.org/10.1007/BF02970136.
(26) Moore, D. J.; West, A. B.; Dawson, V. L.; Dawson, T. M. Molecular Pathophysiology of Parkinson’s Disease. Annu. Rev. Neurosci. 2005, 28, 57–87. https://doi.org/10.1146/annurev.neuro.28.061604.135718.
(27) Aguiar, L. M. V.; Nobre, H. V.; Macêdo, D. S.; Oliveira, A. A.; Freitas, R. M.; Vasconcelos, S. M.; Cunha, G. M. A.; Sousa, F. C. F.; Viana, G. S. B. Neuroprotective Effects of Caffeine in the Model of 6-Hydroxydopamine Lesion in Rats. Pharmacol. Biochem. Behav. 2006, 84 (3), 415–419. https://doi.org/10.1016/j.pbb.2006.05.027.
(28) Haddad, D.; Nakamura, K. Understanding the Susceptibility of Dopamine Neurons to Mitochondrial Stressors in Parkinson’s Disease. FEBS Lett 2015, 589 (24 0 0), 3702–3713. https://doi.org/10.1016/j.febslet.2015.10.021.
(29) Liu, X.-L.; Wang, Y.-D.; Yu, X.-M.; Li, D.-W.; Li, G.-R. Mitochondria-Mediated Damage to Dopaminergic Neurons in Parkinson’s Disease (Review). Int. J. Mol. Med. 2018, 41 (2), 615–623. https://doi.org/10.3892/ijmm.2017.3255.
(30) Fetisova, E.; Chernyak, B.; Korshunova, G.; Muntyan, M.; Skulachev, V. Mitochondria-Targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis. Curr. Med. Chem. 2017, 24 (19), 2086–2114. https://doi.org/10.2174/0929867324666170316114452.
(31) de Barcelos, I. P.; Troxell, R. M.; Graves, J. S. Mitochondrial Dysfunction and Multiple Sclerosis. Biology (Basel) 2019, 8 (2). https://doi.org/10.3390/biology8020037.
(32) Weinberg, S. E.; Sena, L. A.; Chandel, N. S. Mitochondria in the Regulation of Innate and Adaptive Immunity. Immunity 2015, 42 (3), 406–417. https://doi.org/10.1016/j.immuni.2015.02.002.
(33) Angajala, A.; Lim, S.; Phillips, J. B.; Kim, J.-H.; Yates, C.; You, Z.; Tan, M. Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism. Front Immunol 2018, 9. https://doi.org/10.3389/fimmu.2018.01605.
(34) Xu, Y.; Shen, J.; Ran, Z. Emerging Views of Mitophagy in Immunity and Autoimmune Diseases. Autophagy 2020, 16 (1), 3–17. https://doi.org/10.1080/15548627.2019.1603547.
(35) Wallace, D. C. Mitochondria and Cancer. Nat Rev Cancer 2012, 12 (10), 685–698. https://doi.org/10.1038/nrc3365.
(36) Zong, W.-X.; Rabinowitz, J. D.; White, E. Mitochondria and Cancer. Mol. Cell 2016, 61 (5), 667–676. https://doi.org/10.1016/j.molcel.2016.02.011.
(37) Vyas, S.; Zaganjor, E.; Haigis, M. C. Mitochondria and Cancer. Cell 2016, 166 (3), 555–566. https://doi.org/10.1016/j.cell.2016.07.002.
(38) Choudhury, A. R.; Singh, K. K. Mitochondrial Determinants of Cancer Health Disparities. Semin Cancer Biol 2017, 47, 125–146. https://doi.org/10.1016/j.semcancer.2017.05.001.
(39) Kume, S.; Uzu, T.; Horiike, K.; Chin-Kanasaki, M.; Isshiki, K.; Araki, S.-I.; Sugimoto, T.; Haneda, M.; Kashiwagi, A.; Koya, D. Calorie Restriction Enhances Cell Adaptation to Hypoxia through Sirt1-Dependent Mitochondrial Autophagy in Mouse Aged Kidney. J. Clin. Invest. 2010, 120 (4), 1043–1055. https://doi.org/10.1172/JCI41376.
(40) Glick, D.; Barth, S.; Macleod, K. F. Autophagy: Cellular and Molecular Mechanisms. J. Pathol. 2010, 221 (1), 3–12. https://doi.org/10.1002/path.2697.
(41) Kroemer, G.; Mariño, G.; Levine, B. Autophagy and the Integrated Stress Response. Mol. Cell 2010, 40 (2), 280–293. https://doi.org/10.1016/j.molcel.2010.09.023.
(42) Pickles, S.; Vigié, P.; Youle, R. J. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance. Curr. Biol. 2018, 28 (4), R170–R185. https://doi.org/10.1016/j.cub.2018.01.004.
(43) Lanza, I. R.; Zabielski, P.; Klaus, K. A.; Morse, D. M.; Heppelmann, C. J.; Bergen, H. R.; Dasari, S.; Walrand, S.; Short, K. R.; Johnson, M. L.; Robinson, M. M.; Schimke, J. M.; Jakaitis, D. R.; Asmann, Y. W.; Sun, Z.; Nair, K. S. Chronic Caloric Restriction Preserves Mitochondrial Function in Senescence without Increasing Mitochondrial Biogenesis. Cell Metab. 2012, 16 (6), 777–788. https://doi.org/10.1016/j.cmet.2012.11.003.
(44) Ning, Y.-C.; Cai, G.-Y.; Zhuo, L.; Gao, J.-J.; Dong, D.; Cui, S.; Feng, Z.; Shi, S.-Z.; Bai, X.-Y.; Sun, X.-F.; Chen, X.-M. Short-Term Calorie Restriction Protects against Renal Senescence of Aged Rats by Increasing Autophagic Activity and Reducing Oxidative Damage. Mech. Ageing Dev. 2013, 134 (11–12), 570–579. https://doi.org/10.1016/j.mad.2013.11.006.
(45) Ueno, T.; Komatsu, M. Autophagy in the Liver: Functions in Health and Disease. Nat Rev Gastroenterol Hepatol 2017, 14 (3), 170–184. https://doi.org/10.1038/nrgastro.2016.185.
(46) Luévano-Martínez, L. A.; Forni, M. F.; Peloggia, J.; Watanabe, I.-S.; Kowaltowski, A. J. Calorie Restriction Promotes Cardiolipin Biosynthesis and Distribution between Mitochondrial Membranes. Mech. Ageing Dev. 2017, 162, 9–17. https://doi.org/10.1016/j.mad.2017.02.004.
(47) Sciarretta, S.; Maejima, Y.; Zablocki, D.; Sadoshima, J. The Role of Autophagy in the Heart. Annual Review of Physiology 2018, 80 (1), 1–26. https://doi.org/10.1146/annurev-physiol-021317-121427.
(48) Jiang, P.; Mizushima, N. Autophagy and Human Diseases. Cell Res 2014, 24 (1), 69–79. https://doi.org/10.1038/cr.2013.161.
(49) Rubinsztein, D. C.; Bento, C. F.; Deretic, V. Therapeutic Targeting of Autophagy in Neurodegenerative and Infectious Diseases. J. Exp. Med. 2015, 212 (7), 979–990. https://doi.org/10.1084/jem.20150956.
(50) Ravanan, P.; Srikumar, I. F.; Talwar, P. Autophagy: The Spotlight for Cellular Stress Responses. Life Sci. 2017, 188, 53–67. https://doi.org/10.1016/j.lfs.2017.08.029.
(51) Li, Q.; Liu, Y.; Sun, M. Autophagy and Alzheimer’s Disease. Cell. Mol. Neurobiol. 2017, 37 (3), 377–388. https://doi.org/10.1007/s10571-016-0386-8.
(52) Moors, T. E.; Hoozemans, J. J. M.; Ingrassia, A.; Beccari, T.; Parnetti, L.; Chartier-Harlin, M.-C.; van de Berg, W. D. J. Therapeutic Potential of Autophagy-Enhancing Agents in Parkinson’s Disease. Mol Neurodegener 2017, 12 (1), 11. https://doi.org/10.1186/s13024-017-0154-3.
(53) Levy, J. M. M.; Towers, C. G.; Thorburn, A. Targeting Autophagy in Cancer. Nat. Rev. Cancer 2017, 17 (9), 528–542. https://doi.org/10.1038/nrc.2017.53.
(54) Sarparanta, J.; García-Macia, M.; Singh, R. Autophagy and Mitochondria in Obesity and Type 2 Diabetes. Curr Diabetes Rev 2017, 13 (4), 352–369. https://doi.org/10.2174/1573399812666160217122530.
(55) Hamano, T.; Hayashi, K.; Shirafuji, N.; Nakamoto, Y. The Implications of Autophagy in Alzheimer’s Disease. Curr Alzheimer Res 2018, 15 (14), 1283–1296. https://doi.org/10.2174/1567205015666181004143432.
(56) Marasco, M. R.; Linnemann, A. K. β-Cell Autophagy in Diabetes Pathogenesis. Endocrinology 2018, 159 (5), 2127–2141. https://doi.org/10.1210/en.2017-03273.
(57) Cerri, S.; Blandini, F. Role of Autophagy in Parkinson’s Disease. Curr. Med. Chem. 2019, 26 (20), 3702–3718. https://doi.org/10.2174/0929867325666180226094351.
(58) Germic, N.; Frangez, Z.; Yousefi, S.; Simon, H.-U. Regulation of the Innate Immune System by Autophagy: Neutrophils, Eosinophils, Mast Cells, NK Cells. Cell Death & Differentiation 2019, 26 (4), 703–714. https://doi.org/10.1038/s41418-019-0295-8.
(59) Levine, B.; Kroemer, G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell 2019, 176 (1–2), 11–42. https://doi.org/10.1016/j.cell.2018.09.048.
(60) Tapia, P. C. Sublethal Mitochondrial Stress with an Attendant Stoichiometric Augmentation of Reactive Oxygen Species May Precipitate Many of the Beneficial Alterations in Cellular Physiology Produced by Caloric Restriction, Intermittent Fasting, Exercise and Dietary Phytonutrients: “Mitohormesis” for Health and Vitality. Medical Hypotheses 2006, 66 (4), 832–843. https://doi.org/10.1016/j.mehy.2005.09.009.
(61) López-Lluch, G.; Hunt, N.; Jones, B.; Zhu, M.; Jamieson, H.; Hilmer, S.; Cascajo, M. V.; Allard, J.; Ingram, D. K.; Navas, P.; de Cabo, R. Calorie Restriction Induces Mitochondrial Biogenesis and Bioenergetic Efficiency. Proc Natl Acad Sci U S A 2006, 103 (6), 1768–1773. https://doi.org/10.1073/pnas.0510452103.
(62) Lettieri-Barbato, D.; Cannata, S. M.; Casagrande, V.; Ciriolo, M. R.; Aquilano, K. Time-Controlled Fasting Prevents Aging-like Mitochondrial Changes Induced by Persistent Dietary Fat Overload in Skeletal Muscle. PLoS One 2018, 13 (5). https://doi.org/10.1371/journal.pone.0195912.
(63) Miller, V. J.; Villamena, F. A.; Volek, J. S. Nutritional Ketosis and Mitohormesis: Potential Implications for Mitochondrial Function and Human Health. J Nutr Metab 2018, 2018. https://doi.org/10.1155/2018/5157645.
(64) Palmeira, C. M.; Teodoro, J. S.; Amorim, J. A.; Steegborn, C.; Sinclair, D. A.; Rolo, A. P. Mitohormesis and Metabolic Health: The Interplay between ROS, CAMP and Sirtuins. Free Radical Biology and Medicine 2019, 141, 483–491. https://doi.org/10.1016/j.freeradbiomed.2019.07.017.
(65) Bagherniya, M.; Butler, A. E.; Barreto, G. E.; Sahebkar, A. The Effect of Fasting or Calorie Restriction on Autophagy Induction: A Review of the Literature. Ageing Res. Rev. 2018, 47, 183–197. https://doi.org/10.1016/j.arr.2018.08.004.
(66) Bach, D.; Pich, S.; Soriano, F. X.; Vega, N.; Baumgartner, B.; Oriola, J.; Daugaard, J. R.; Lloberas, J.; Camps, M.; Zierath, J. R.; Rabasa-Lhoret, R.; Wallberg-Henriksson, H.; Laville, M.; Palacín, M.; Vidal, H.; Rivera, F.; Brand, M.; Zorzano, A. Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism. A Novel Regulatory Mechanism Altered in Obesity. J. Biol. Chem. 2003, 278 (19), 17190–17197. https://doi.org/10.1074/jbc.M212754200.
(67) Ma, D.; Li, S.; Molusky, M. M.; Lin, J. D. Circadian Autophagy Rhythm: A Link between Clock and Metabolism? Trends Endocrinol. Metab. 2012, 23 (7), 319–325. https://doi.org/10.1016/j.tem.2012.03.004.
(68) Maiese, K. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, MTOR, and SIRT1 in Degenerative Disease and Cancer. Curr Neurovasc Res 2017, 14 (3), 299–304. https://doi.org/10.2174/1567202614666170718092010.
(69) Rabbani, N.; Thornalley, P. J. Dicarbonyls Linked to Damage in the Powerhouse: Glycation of Mitochondrial Proteins and Oxidative Stress. Biochem Soc Trans 2008, 36 (Pt 5), 1045–1050. https://doi.org/10.1042/BST0361045.
(70) Naudí, A.; Jové, M.; Ayala, V.; Portero-Otín, M.; Pamplona, R. [Glycation of mitochondrial proteins, oxidative stress and aging]. Rev Esp Geriatr Gerontol 2010, 45 (3), 156–166. https://doi.org/10.1016/j.regg.2010.02.001.
(71) Balsano, C.; Alisi, A. Antioxidant Effects of Natural Bioactive Compounds. Curr. Pharm. Des. 2009, 15 (26), 3063–3073. https://doi.org/10.2174/138161209789058084.
(72) Ibanez, F.; Bang, W. Y.; Lombardini, L.; Cisneros-Zevallos, L. Solving the Controversy of Healthier Organic Fruit: Leaf Wounding Triggers Distant Gene Expression Response of Polyphenol Biosynthesis in Strawberry Fruit (Fragaria x Ananassa). Sci Rep 2019, 9. https://doi.org/10.1038/s41598-019-55033-w.
(73) Soane, L.; Li Dai, W.; Fiskum, G.; Bambrick, L. L. Sulforaphane Protects Immature Hippocampal Neurons against Death Caused by Exposure to Hemin or to Oxygen and Glucose Deprivation. J. Neurosci. Res. 2010, 88 (6), 1355–1363. https://doi.org/10.1002/jnr.22307.
(74) de Oliveira, M. R.; Nabavi, S. M.; Braidy, N.; Setzer, W. N.; Ahmed, T.; Nabavi, S. F. Quercetin and the Mitochondria: A Mechanistic View. Biotechnol. Adv. 2016, 34 (5), 532–549. https://doi.org/10.1016/j.biotechadv.2015.12.014.
(75) Chen, X.; Peng, X.; Luo, Y.; You, J.; Yin, D.; Xu, Q.; He, H.; He, M. Quercetin Protects Cardiomyocytes against Doxorubicin-Induced Toxicity by Suppressing Oxidative Stress and Improving Mitochondrial Function via 14-3-3γ. Toxicol. Mech. Methods 2019, 29 (5), 344–354. https://doi.org/10.1080/15376516.2018.1564948.
(76) Amanzadeh, E.; Esmaeili, A.; Rahgozar, S.; Nourbakhshnia, M. Application of Quercetin in Neurological Disorders: From Nutrition to Nanomedicine. Rev Neurosci 2019, 30 (5), 555–572. https://doi.org/10.1515/revneuro-2018-0080.
(77) Wu, C.; Hsu, M.; Hsieh, C.; Lin, J.; Lai, P.; Wung, B. Upregulation of Heme Oxygenase-1 by Epigallocatechin-3-Gallate via the Phosphatidylinositol 3-Kinase/Akt and ERK Pathways. Life Sci 2005, 78 (25), 2889–2897. https://doi.org/10.1016/j.lfs.2005.11.013.
(78) Schroeder, E. K.; Kelsey, N. A.; Doyle, J.; Breed, E.; Bouchard, R. J.; Loucks, F. A.; Harbison, R. A.; Linseman, D. A. Green Tea Epigallocatechin 3-Gallate Accumulates in Mitochondria and Displays a Selective Antiapoptotic Effect against Inducers of Mitochondrial Oxidative Stress in Neurons. Antioxid. Redox Signal. 2009, 11 (3), 469–480. https://doi.org/10.1089/ars.2008.2215.
(79) Oliveira, M. R. de; Nabavi, S. F.; Daglia, M.; Rastrelli, L.; Nabavi, S. M. Epigallocatechin Gallate and Mitochondria-A Story of Life and Death. Pharmacol. Res. 2016, 104, 70–85. https://doi.org/10.1016/j.phrs.2015.12.027.
(80) Shi, W.; Li, L.; Ding, Y.; Yang, K.; Chen, Z.; Fan, X.; Jiang, S.; Guan, Y.; Liu, Z.; Xu, D.; Wu, L. The Critical Role of Epigallocatechin Gallate in Regulating Mitochondrial Metabolism. Future Med Chem 2018, 10 (7), 795–809. https://doi.org/10.4155/fmc-2017-0204.
(81) Pae, H.-O.; Jeong, G.-S.; Jeong, S.-O.; Kim, H. S.; Kim, S.-A.; Kim, Y.-C.; Yoo, S.-J.; Kim, H.-D.; Chung, H.-T. Roles of Heme Oxygenase-1 in Curcumin-Induced Growth Inhibition in Rat Smooth Muscle Cells. Exp. Mol. Med. 2007, 39 (3), 267–277. https://doi.org/10.1038/emm.2007.30.
(82) Wu, W.; Yang, B.; Qiao, Y.; Zhou, Q.; He, H.; He, M. Kaempferol Protects Mitochondria and Alleviates Damages against Endotheliotoxicity Induced by Doxorubicin. Biomed. Pharmacother. 2020, 126, 110040. https://doi.org/10.1016/j.biopha.2020.110040.
(83) Hsieh, T.; Lu, X.; Wang, Z.; Wu, J. M. Induction of Quinone Reductase NQO1 by Resveratrol in Human K562 Cells Involves the Antioxidant Response Element ARE and Is Accompanied by Nuclear Translocation of Transcription Factor Nrf2. Med Chem 2006, 2 (3), 275–285. https://doi.org/10.2174/157340606776930709.
(84) Valero, T. Mitochondrial Biogenesis: Pharmacological Approaches. Curr. Pharm. Des. 2014, 20 (35), 5507–5509. https://doi.org/10.2174/138161282035140911142118.
(85) Tellone, E.; Galtieri, A.; Russo, A.; Giardina, B.; Ficarra, S. Resveratrol: A Focus on Several Neurodegenerative Diseases. Oxid Med Cell Longev 2015, 2015, 392169. https://doi.org/10.1155/2015/392169.
(86) de Oliveira, M. R.; Nabavi, S. F.; Manayi, A.; Daglia, M.; Hajheydari, Z.; Nabavi, S. M. Resveratrol and the Mitochondria: From Triggering the Intrinsic Apoptotic Pathway to Inducing Mitochondrial Biogenesis, a Mechanistic View. Biochim. Biophys. Acta 2016, 1860 (4), 727–745. https://doi.org/10.1016/j.bbagen.2016.01.017.
(87) Kairisalo, M.; Bonomo, A.; Hyrskyluoto, A.; Mudò, G.; Belluardo, N.; Korhonen, L.; Lindholm, D. Resveratrol Reduces Oxidative Stress and Cell Death and Increases Mitochondrial Antioxidants and XIAP in PC6.3-Cells. Neurosci. Lett. 2011, 488 (3), 263–266. https://doi.org/10.1016/j.neulet.2010.11.042.
(88) Zhao, H.; Niu, Q.; Li, X.; Liu, T.; Xu, Y.; Han, H.; Wang, W.; Fan, N.; Tian, Q.; Zhang, H.; Wang, Z. Long-Term Resveratrol Consumption Protects Ovariectomized Rats Chronically Treated with D-Galactose from Developing Memory Decline without Effects on the Uterus. Brain Res. 2012, 1467, 67–80. https://doi.org/10.1016/j.brainres.2012.05.040.
(89) Wu, Y.; Li, X.; Zhu, J. X.; Xie, W.; Le, W.; Fan, Z.; Jankovic, J.; Pan, T. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease. Neurosignals 2011, 19 (3), 163–174. https://doi.org/10.1159/000328516.
(90) Lin, T.-K.; Chen, S.-D.; Chuang, Y.-C.; Lin, H.-Y.; Huang, C.-R.; Chuang, J.-H.; Wang, P.-W.; Huang, S.-T.; Tiao, M.-M.; Chen, J.-B.; Liou, C.-W. Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy. Int J Mol Sci 2014, 15 (1), 1625–1646. https://doi.org/10.3390/ijms15011625.
(91) De Paepe, B.; Van Coster, R. A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders. Nutrients 2017, 9 (9). https://doi.org/10.3390/nu9091017.
(92) Jardim, F. R.; de Rossi, F. T.; Nascimento, M. X.; da Silva Barros, R. G.; Borges, P. A.; Prescilio, I. C.; de Oliveira, M. R. Resveratrol and Brain Mitochondria: A Review. Mol. Neurobiol. 2018, 55 (3), 2085–2101. https://doi.org/10.1007/s12035-017-0448-z.
(93) Ahmed, T.; Javed, S.; Javed, S.; Tariq, A.; Šamec, D.; Tejada, S.; Nabavi, S. F.; Braidy, N.; Nabavi, S. M. Resveratrol and Alzheimer’s Disease: Mechanistic Insights. Mol. Neurobiol. 2017, 54 (4), 2622–2635. https://doi.org/10.1007/s12035-016-9839-9.
(94) Schweiger, S.; Matthes, F.; Posey, K.; Kickstein, E.; Weber, S.; Hettich, M. M.; Pfurtscheller, S.; Ehninger, D.; Schneider, R.; Krauß, S. Resveratrol Induces Dephosphorylation of Tau by Interfering with the MID1-PP2A Complex. Scientific Reports 2017, 7 (1), 1–13. https://doi.org/10.1038/s41598-017-12974-4.
(95) Kou, X.; Chen, N. Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer’s Disease. Nutrients 2017, 9 (9). https://doi.org/10.3390/nu9090927.
(96) Gomes, B. A. Q.; Silva, J. P. B.; Romeiro, C. F. R.; dos Santos, S. M.; Rodrigues, C. A.; Gonçalves, P. R.; Sakai, J. T.; Mendes, P. F. S.; Varela, E. L. P.; Monteiro, M. C. Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1. Oxid Med Cell Longev 2018, 2018. https://doi.org/10.1155/2018/8152373.
(97) Ferretta, A.; Gaballo, A.; Tanzarella, P.; Piccoli, C.; Capitanio, N.; Nico, B.; Annese, T.; Di Paola, M.; Dell’aquila, C.; De Mari, M.; Ferranini, E.; Bonifati, V.; Pacelli, C.; Cocco, T. Effect of Resveratrol on Mitochondrial Function: Implications in Parkin-Associated Familiar Parkinson’s Disease. Biochim. Biophys. Acta 2014, 1842 (7), 902–915. https://doi.org/10.1016/j.bbadis.2014.02.010.
(98) Peng, K.; Tao, Y.; Zhang, J.; Wang, J.; Ye, F.; Dan, G.; Zhao, Y.; Cai, Y.; Zhao, J.; Wu, Q.; Zou, Z.; Cao, J.; Sai, Y. Resveratrol Regulates Mitochondrial Biogenesis and Fission/Fusion to Attenuate Rotenone-Induced Neurotoxicity. Oxid Med Cell Longev 2016, 2016, 6705621. https://doi.org/10.1155/2016/6705621.
(99) Palle, S.; Neerati, P. Improved Neuroprotective Effect of Resveratrol Nanoparticles as Evinced by Abrogation of Rotenone-Induced Behavioral Deficits and Oxidative and Mitochondrial Dysfunctions in Rat Model of Parkinson’s Disease. Naunyn Schmiedebergs Arch. Pharmacol. 2018, 391 (4), 445–453. https://doi.org/10.1007/s00210-018-1474-8.
(100) Naia, L.; Rosenstock, T. R.; Oliveira, A. M.; Oliveira-Sousa, S. I.; Caldeira, G. L.; Carmo, C.; Laço, M. N.; Hayden, M. R.; Oliveira, C. R.; Rego, A. C. Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models. Mol. Neurobiol. 2017, 54 (7), 5385–5399. https://doi.org/10.1007/s12035-016-0048-3.
(101) Mancuso, R.; del Valle, J.; Modol, L.; Martinez, A.; Granado-Serrano, A. B.; Ramirez-Núñez, O.; Pallás, M.; Portero-Otin, M.; Osta, R.; Navarro, X. Resveratrol Improves Motoneuron Function and Extends Survival in SOD1(G93A) ALS Mice. Neurotherapeutics 2014, 11 (2), 419–432. https://doi.org/10.1007/s13311-013-0253-y.
(102) Pollack, R. M.; Barzilai, N.; Anghel, V.; Kulkarni, A. S.; Golden, A.; O’Broin, P.; Sinclair, D. A.; Bonkowski, M. S.; Coleville, A. J.; Powell, D.; Kim, S.; Moaddel, R.; Stein, D.; Zhang, K.; Hawkins, M.; Crandall, J. P. Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults. J. Gerontol. A Biol. Sci. Med. Sci. 2017, 72 (12), 1703–1709. https://doi.org/10.1093/gerona/glx041.
(103) de Ligt, M.; Bruls, Y. M. H.; Hansen, J.; Habets, M.-F.; Havekes, B.; Nascimento, E. B. M.; Moonen-Kornips, E.; Schaart, G.; Schrauwen-Hinderling, V. B.; van Marken Lichtenbelt, W.; Schrauwen, P. Resveratrol Improves Ex Vivo Mitochondrial Function but Does Not Affect Insulin Sensitivity or Brown Adipose Tissue in First Degree Relatives of Patients with Type 2 Diabetes. Mol Metab 2018, 12, 39–47. https://doi.org/10.1016/j.molmet.2018.04.004.
(104) Barrea, L.; Tarantino, G.; Somma, C. D.; Muscogiuri, G.; Macchia, P. E.; Falco, A.; Colao, A.; Savastano, S. Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association. Oxid Med Cell Longev 2017, 2017. https://doi.org/10.1155/2017/6101254.
(105) Caplliure-Llopis, J.; Peralta-Chamba, T.; Carrera-Juliá, S.; Cuerda-Ballester, M.; Drehmer-Rieger, E.; López-Rodriguez, M. M.; de la Rubia Ortí, J. E. Therapeutic Alternative of the Ketogenic Mediterranean Diet to Improve Mitochondrial Activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review. Food Sci Nutr 2020, 8 (1), 23–35. https://doi.org/10.1002/fsn3.1324.
(106) Lonn, E.; Bosch, J.; Yusuf, S.; Sheridan, P.; Pogue, J.; Arnold, J. M. O.; Ross, C.; Arnold, A.; Sleight, P.; Probstfield, J.; Dagenais, G. R.; HOPE and HOPE-TOO Trial Investigators. Effects of Long-Term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial. JAMA 2005, 293 (11), 1338–1347. https://doi.org/10.1001/jama.293.11.1338.
(107) Bjelakovic, G.; Nikolova, D.; Gluud, L. L.; Simonetti, R. G.; Gluud, C. Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-Analysis. JAMA 2007, 297 (8), 842–857. https://doi.org/10.1001/jama.297.8.842.
(108) Lippman, S. M.; Klein, E. A.; Goodman, P. J.; Lucia, M. S.; Thompson, I. M.; Ford, L. G.; Parnes, H. L.; Minasian, L. M.; Gaziano, J. M.; Hartline, J. A.; Parsons, J. K.; Bearden, J. D.; Crawford, E. D.; Goodman, G. E.; Claudio, J.; Winquist, E.; Cook, E. D.; Karp, D. D.; Walther, P.; Lieber, M. M.; Kristal, A. R.; Darke, A. K.; Arnold, K. B.; Ganz, P. A.; Santella, R. M.; Albanes, D.; Taylor, P. R.; Probstfield, J. L.; Jagpal, T. J.; Crowley, J. J.; Meyskens, F. L.; Baker, L. H.; Coltman, C. A. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301 (1), 39–51. https://doi.org/10.1001/jama.2008.864.
(109) Lin, J.; Cook, N.; Albert, C.; Zaharris, E.; Gaziano, J.; Van Denburgh, M.; Buring, J.; Manson, J. Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial. Journal of the National Cancer Institute 2009, 101, 14–23. https://doi.org/10.1093/jnci/djn438.
(110) Wang, X. H.; Souders, C. L.; Zhao, Y. H.; Martyniuk, C. J. Paraquat Affects Mitochondrial Bioenergetics, Dopamine System Expression, and Locomotor Activity in Zebrafish (Danio Rerio). Chemosphere 2018, 191, 106–117. https://doi.org/10.1016/j.chemosphere.2017.10.032.
(111) Castello, P. R.; Drechsel, D. A.; Patel, M. Mitochondria Are a Major Source of Paraquat-Induced Reactive Oxygen Species Production in the Brain. J. Biol. Chem. 2007, 282 (19), 14186–14193. https://doi.org/10.1074/jbc.M700827200.
(112) Cochemé, H. M.; Murphy, M. P. Complex I Is the Major Site of Mitochondrial Superoxide Production by Paraquat. J. Biol. Chem. 2008, 283 (4), 1786–1798. https://doi.org/10.1074/jbc.M708597200.
(113) Blanco-Ayala, T.; Andérica-Romero, A. C.; Pedraza-Chaverri, J. New Insights into Antioxidant Strategies against Paraquat Toxicity. Free Radic. Res. 2014, 48 (6), 623–640. https://doi.org/10.3109/10715762.2014.899694.
(114) Jang, Y. J.; Won, J. H.; Back, M. J.; Fu, Z.; Jang, J. M.; Ha, H. C.; Hong, S.; Chang, M.; Kim, D. K. Paraquat Induces Apoptosis through a Mitochondria-Dependent Pathway in RAW264.7 Cells. Biomol Ther (Seoul) 2015, 23 (5), 407–413. https://doi.org/10.4062/biomolther.2015.075.
(115) Huang, C.-L.; Chao, C.-C.; Lee, Y.-C.; Lu, M.-K.; Cheng, J.-J.; Yang, Y.-C.; Wang, V.-C.; Chang, W.-C.; Huang, N.-K. Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability. Mol. Neurobiol. 2016, 53 (4), 2169–2188. https://doi.org/10.1007/s12035-015-9198-y.
(116) Samsel, A.; Seneff, S. Glyphosate, Pathways to Modern Diseases III: Manganese, Neurological Diseases, and Associated Pathologies. Surg Neurol Int 2015, 6, 45. https://doi.org/10.4103/2152-7806.153876.
(117) Bailey, D. C.; Todt, C. E.; Burchfield, S. L.; Pressley, A. S.; Denney, R. D.; Snapp, I. B.; Negga, R.; Traynor, W. L.; Fitsanakis, V. A. Chronic Exposure to a Glyphosate-Containing Pesticide Leads to Mitochondrial Dysfunction and Increased Reactive Oxygen Species Production in Caenorhabditis Elegans. Environ. Toxicol. Pharmacol. 2018, 57, 46–52. https://doi.org/10.1016/j.etap.2017.11.005.
(118) Kronberg, M. F.; Clavijo, A.; Moya, A.; Rossen, A.; Calvo, D.; Pagano, E.; Munarriz, E. Glyphosate-Based Herbicides Modulate Oxidative Stress Response in the Nematode Caenorhabditis Elegans. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2018, 214, 1–8. https://doi.org/10.1016/j.cbpc.2018.08.002.
(119) Pereira, A. G.; Jaramillo, M. L.; Remor, A. P.; Latini, A.; Davico, C. E.; da Silva, M. L.; Müller, Y. M. R.; Ammar, D.; Nazari, E. M. Low-Concentration Exposure to Glyphosate-Based Herbicide Modulates the Complexes of the Mitochondrial Respiratory Chain and Induces Mitochondrial Hyperpolarization in the Danio Rerio Brain. Chemosphere 2018, 209, 353–362. https://doi.org/10.1016/j.chemosphere.2018.06.075.
(120) Burchfield, S. L.; Bailey, D. C.; Todt, C. E.; Denney, R. D.; Negga, R.; Fitsanakis, V. A. Acute Exposure to a Glyphosate-Containing Herbicide Formulation Inhibits Complex II and Increases Hydrogen Peroxide in the Model Organism Caenorhabditis Elegans. Environ. Toxicol. Pharmacol. 2019, 66, 36–42. https://doi.org/10.1016/j.etap.2018.12.019.
(121) Hao, Y.; Chen, H.; Xu, W.; Gao, J.; Yang, Y.; Zhang, Y.; Tao, L. Roundup® Confers Cytotoxicity through DNA Damage and Mitochondria-Associated Apoptosis Induction. Environ. Pollut. 2019, 252 (Pt A), 917–923. https://doi.org/10.1016/j.envpol.2019.05.128.
(122) Zhang, J.-W.; Xu, D.-Q.; Feng, X.-Z. The Toxic Effects and Possible Mechanisms of Glyphosate on Mouse Oocytes. Chemosphere 2019, 237, 124435. https://doi.org/10.1016/j.chemosphere.2019.124435.
(123) Cavieres, M. F.; Jaeger, J.; Porter, W. Developmental Toxicity of a Commercial Herbicide Mixture in Mice: I. Effects on Embryo Implantation and Litter Size. Environ Health Perspect 2002, 110 (11), 1081–1085.
(124) Peixoto, F.; Vicente, J. A. F.; Madeira, V. M. C. Comparative Effects of Herbicide Dicamba and Related Compound on Plant Mitochondrial Bioenergetics. J. Biochem. Mol. Toxicol. 2003, 17 (3), 185–192. https://doi.org/10.1002/jbt.10077.
(125) Peixoto, F.; Vicente, J. A. F.; Madeira, V. M. C. The Herbicide Dicamba (2-Methoxy-3,6-Dichlorobenzoic Acid) Interacts with Mitochondrial Bioenergetic Functions. Arch. Toxicol. 2003, 77 (7), 403–409. https://doi.org/10.1007/s00204-003-0456-9.
(126) Middlemore-Risher, M.-L.; Adam, B.-L.; Lambert, N. A.; Terry, A. V. Effects of Chlorpyrifos and Chlorpyrifos-Oxon on the Dynamics and Movement of Mitochondria in Rat Cortical Neurons. J. Pharmacol. Exp. Ther. 2011, 339 (2), 341–349. https://doi.org/10.1124/jpet.111.184762.
(127) Yamada, S.; Kubo, Y.; Yamazaki, D.; Sekino, Y.; Kanda, Y. Chlorpyrifos Inhibits Neural Induction via Mfn1-Mediated Mitochondrial Dysfunction in Human Induced Pluripotent Stem Cells. Sci Rep 2017, 7, 40925. https://doi.org/10.1038/srep40925.
(128) Donley, N. The USA Lags behind Other Agricultural Nations in Banning Harmful Pesticides. Environ Health 2019, 18 (1), 44. https://doi.org/10.1186/s12940-019-0488-0.
(129) Lim, S.; Ahn, S. Y.; Song, I. C.; Chung, M. H.; Jang, H. C.; Park, K. S.; Lee, K.-U.; Pak, Y. K.; Lee, H. K. Chronic Exposure to the Herbicide, Atrazine, Causes Mitochondrial Dysfunction and Insulin Resistance. PLoS ONE 2009, 4 (4), e5186. https://doi.org/10.1371/journal.pone.0005186.
(130) Sagarkar, S.; Gandhi, D.; Devi, S. S.; Sakharkar, A.; Kapley, A. Atrazine Exposure Causes Mitochondrial Toxicity in Liver and Muscle Cell Lines. Indian J Pharmacol 2016, 48 (2), 200–207. https://doi.org/10.4103/0253-7613.178842.
(131) Lin, J.; Zhao, H.-S.; Qin, L.; Li, X.-N.; Zhang, C.; Xia, J.; Li, J.-L. Atrazine Triggers Mitochondrial Dysfunction and Oxidative Stress in Quail ( Coturnix C. Coturnix) Cerebrum via Activating Xenobiotic-Sensing Nuclear Receptors and Modulating Cytochrome P450 Systems. J. Agric. Food Chem. 2018, 66 (25), 6402–6413. https://doi.org/10.1021/acs.jafc.8b01413.
(132) Zhang, C.; Qin, L.; Dou, D.-C.; Li, X.-N.; Ge, J.; Li, J.-L. Atrazine Induced Oxidative Stress and Mitochondrial Dysfunction in Quail (Coturnix C. Coturnix) Kidney via Modulating Nrf2 Signaling Pathway. Chemosphere 2018, 212, 974–982. https://doi.org/10.1016/j.chemosphere.2018.08.138.
(133) Yang, M.; Wang, B.; Gao, J.; Zhang, Y.; Xu, W.; Tao, L. Spinosad Induces Programmed Cell Death Involves Mitochondrial Dysfunction and Cytochrome C Release in Spodoptera Frugiperda Sf9 Cells. Chemosphere 2017, 169, 155–161. https://doi.org/10.1016/j.chemosphere.2016.11.065.
(134) Zhang, Y.; Chen, H.; Fan, Y.; Yang, Y.; Gao, J.; Xu, W.; Xu, Z.; Li, Z.; Tao, L. Cytotoxic Effects of Bio-Pesticide Spinosad on Human Lung A549 cells. Chemosphere 2019, 230, 182–189. https://doi.org/10.1016/j.chemosphere.2019.05.042.
(135) Brazeau, M. 4 Things That Led to the Myth That Organic Farmers Use More Pesticides than Conventional Farmers. Genetic Literacy Project. May 22, 2018.
(136) Navarro, A.; Bández, M. J.; Gómez, C.; Repetto, M. G.; Boveris, A. Effects of Rotenone and Pyridaben on Complex I Electron Transfer and on Mitochondrial Nitric Oxide Synthase Functional Activity. J. Bioenerg. Biomembr. 2010, 42 (5), 405–412. https://doi.org/10.1007/s10863-010-9309-4.
(137) Heinz, S.; Freyberger, A.; Lawrenz, B.; Schladt, L.; Schmuck, G.; Ellinger-Ziegelbauer, H. Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation. Sci Rep 2017, 7, 45465. https://doi.org/10.1038/srep45465.
(138) Xu, W.; Liu, W.; Shao, X.; Jiang, G.; Li, X. Effect of Trichlorfon on Hepatic Lipid Accumulation in Crucian Carp Carassius Auratus Gibelio. J. Aquat. Anim. Health 2012, 24 (3), 185–194. https://doi.org/10.1080/08997659.2012.675937.
(139) Lu, J.; Zhang, M.; Lu, L. Tissue Metabolism, Hematotoxicity, and Hepatotoxicity of Trichlorfon in Carassius Auratus Gibelio After a Single Oral Administration. Front Physiol 2018, 9, 551. https://doi.org/10.3389/fphys.2018.00551.
(140) EPA. Trichlorfon – Regulatory Actions https://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:31:::NO:1,3,31,7,12,25:P3_XCHEMICAL_ID:4102 (accessed May 3, 2020).
(141) Nakamaru-Ogiso, E.; Sakamoto, K.; Matsuno-Yagi, A.; Miyoshi, H.; Yagi, T. The ND5 Subunit Was Labeled by a Photoaffinity Analogue of Fenpyroximate in Bovine Mitochondrial Complex I. Biochemistry 2003, 42 (3), 746–754. https://doi.org/10.1021/bi0269660.
(142) Sherer, T. B.; Richardson, J. R.; Testa, C. M.; Seo, B. B.; Panov, A. V.; Yagi, T.; Matsuno-Yagi, A.; Miller, G. W.; Greenamyre, J. T. Mechanism of Toxicity of Pesticides Acting at Complex I: Relevance to Environmental Etiologies of Parkinson’s Disease. J. Neurochem. 2007, 100 (6), 1469–1479. https://doi.org/10.1111/j.1471-4159.2006.04333.x.
(143) Lee, H. Y.; Lee, B. K.; Jeung, K. W.; Lee, G. S.; Jung, Y. H.; Jeong, I. S. A Case of Near-Fatal Fenpyroximate Intoxication: The Role of Percutaneous Cardiopulmonary Support and Therapeutic Hypothermia. Clin Toxicol (Phila) 2012, 50 (9), 858–861. https://doi.org/10.3109/15563650.2012.720987.
(144) Chen, T.; Tan, J.; Wan, Z.; Zou, Y.; Afewerky, H. K.; Zhang, Z.; Zhang, T. Effects of Commonly Used Pesticides in China on the Mitochondria and Ubiquitin-Proteasome System in Parkinson’s Disease. Int J Mol Sci 2017, 18 (12). https://doi.org/10.3390/ijms18122507.
(145) Bailey, D. C.; Todt, C. E.; Orfield, S. E.; Denney, R. D.; Snapp, I. B.; Negga, R.; Montgomery, K. M.; Bailey, A. C.; Pressley, A. S.; Traynor, W. L.; Fitsanakis, V. A. Caenorhabditis Elegans Chronically Exposed to a Mn/Zn Ethylene-Bis-Dithiocarbamate Fungicide Show Mitochondrial Complex I Inhibition and Increased Reactive Oxygen Species. Neurotoxicology 2016, 56, 170–179. https://doi.org/10.1016/j.neuro.2016.07.011.
(146) Todt, C. E.; Bailey, D. C.; Pressley, A. S.; Orfield, S. E.; Denney, R. D.; Snapp, I. B.; Negga, R.; Bailey, A. C.; Montgomery, K. M.; Traynor, W. L.; Fitsanakis, V. A. Acute Exposure to a Mn/Zn Ethylene-Bis-Dithiocarbamate Fungicide Leads to Mitochondrial Dysfunction and Increased Reactive Oxygen Species Production in Caenorhabditis Elegans. Neurotoxicology 2016, 57, 112–120. https://doi.org/10.1016/j.neuro.2016.09.011.
(147) Briquet, M.; Sabadie-Pialoux, N.; Goffeau, A. Ziram, a Sulfhydryl Reagent and Specific Inhibitor of Yeast Mitochondrial Dehydrogenases. Arch. Biochem. Biophys. 1976, 174 (2), 684–694. https://doi.org/10.1016/0003-9861(76)90399-4.
(148) Li, Q.; Kobayashi, M.; Kawada, T. Ziram Induces Apoptosis and Necrosis in Human Immune Cells. Arch. Toxicol. 2011, 85 (4), 355–361. https://doi.org/10.1007/s00204-010-0586-9.
(149) Li, Q.; Kobayashi, M.; Kawada, T. Mechanism of Ziram-Induced Apoptosis in Human Natural Killer Cells. Int J Immunopathol Pharmacol 2012, 25 (4), 883–891. https://doi.org/10.1177/039463201202500406.
(150) Martin, C. A.; Myers, K. M.; Chen, A.; Martin, N. T.; Barajas, A.; Schweizer, F. E.; Krantz, D. E. Ziram, a Pesticide Associated with Increased Risk for Parkinson’s Disease, Differentially Affects the Presynaptic Function of Aminergic and Glutamatergic Nerve Terminals at the Drosophila Neuromuscular Junction. Exp Neurol 2016, 275 (0 1), 232–241. https://doi.org/10.1016/j.expneurol.2015.09.017.
(151) Béranger, R.; Billoir, E.; Nuckols, J. R.; Blain, J.; Millet, M.; Bayle, M.-L.; Combourieu, B.; Philip, T.; Schüz, J.; Fervers, B. Agricultural and Domestic Pesticides in House Dust from Different Agricultural Areas in France. Environ Sci Pollut Res Int 2019, 26 (19), 19632–19645. https://doi.org/10.1007/s11356-019-05313-9.
(152) Butenhoff, J. L.; Ehresman, D. J.; Chang, S.-C.; Parker, G. A.; Stump, D. G. Gestational and Lactational Exposure to Potassium Perfluorooctanesulfonate (K+PFOS) in Rats: Developmental Neurotoxicity. Reprod. Toxicol. 2009, 27 (3–4), 319–330. https://doi.org/10.1016/j.reprotox.2008.12.010.
(153) Butenhoff, J. L.; Bjork, J. A.; Chang, S.-C.; Ehresman, D. J.; Parker, G. A.; Das, K.; Lau, C.; Lieder, P. H.; van Otterdijk, F. M.; Wallace, K. B. Toxicological Evaluation of Ammonium Perfluorobutyrate in Rats: Twenty-Eight-Day and Ninety-Day Oral Gavage Studies. Reprod. Toxicol. 2012, 33 (4), 513–530. https://doi.org/10.1016/j.reprotox.2011.08.004.
(154) Belyaeva, E. A.; Sokolova, T. V.; Emelyanova, L. V.; Zakharova, I. O. Mitochondrial Electron Transport Chain in Heavy Metal-Induced Neurotoxicity: Effects of Cadmium, Mercury, and Copper. ScientificWorldJournal 2012, 2012. https://doi.org/10.1100/2012/136063.
(155) Belyaeva, E. A.; Dymkowska, D.; Wieckowski, M. R.; Wojtczak, L. Mitochondria as an Important Target in Heavy Metal Toxicity in Rat Hepatoma AS-30D Cells. Toxicol. Appl. Pharmacol. 2008, 231 (1), 34–42. https://doi.org/10.1016/j.taap.2008.03.017.
(156) Borchard, S.; Bork, F.; Rieder, T.; Eberhagen, C.; Popper, B.; Lichtmannegger, J.; Schmitt, S.; Adamski, J.; Klingenspor, M.; Weiss, K.-H.; Zischka, H. The Exceptional Sensitivity of Brain Mitochondria to Copper. Toxicol In Vitro 2018, 51, 11–22. https://doi.org/10.1016/j.tiv.2018.04.012.
(157) Isei, M. O.; Kamunde, C. Effects of Copper and Temperature on Heart Mitochondrial Hydrogen Peroxide Production. Free Radic. Biol. Med. 2020, 147, 114–128. https://doi.org/10.1016/j.freeradbiomed.2019.12.006.
(158) Zischka, H.; Lichtmannegger, J.; Schmitt, S.; Jägemann, N.; Schulz, S.; Wartini, D.; Jennen, L.; Rust, C.; Larochette, N.; Galluzzi, L.; Chajes, V.; Bandow, N.; Gilles, V. S.; DiSpirito, A. A.; Esposito, I.; Goettlicher, M.; Summer, K. H.; Kroemer, G. Liver Mitochondrial Membrane Crosslinking and Destruction in a Rat Model of Wilson Disease. J. Clin. Invest. 2011, 121 (4), 1508–1518. https://doi.org/10.1172/JCI45401.
(159) Zischka, H.; Lichtmannegger, J. Pathological Mitochondrial Copper Overload in Livers of Wilson’s Disease Patients and Related Animal Models. Ann. N. Y. Acad. Sci. 2014, 1315, 6–15. https://doi.org/10.1111/nyas.12347.
(160) Spiller, H. A. Rethinking Mercury: The Role of Selenium in the Pathophysiology of Mercury Toxicity. Clin Toxicol (Phila) 2018, 56 (5), 313–326. https://doi.org/10.1080/15563650.2017.1400555.
(161) Lund, B. O.; Miller, D. M.; Woods, J. S. Mercury-Induced H2O2 Production and Lipid Peroxidation in Vitro in Rat Kidney Mitochondria. Biochem. Pharmacol. 1991, 42 Suppl, S181-187. https://doi.org/10.1016/0006-2952(91)90408-w.
(162) Lund, B. O.; Miller, D. M.; Woods, J. S. Studies on Hg(II)-Induced H2O2 Formation and Oxidative Stress in Vivo and in Vitro in Rat Kidney Mitochondria. Biochem. Pharmacol. 1993, 45 (10), 2017–2024. https://doi.org/10.1016/0006-2952(93)90012-l.
(163) Dua, R.; Sunkaria, A.; Kumar, V.; Gill, K. D. Impaired Mitochondrial Energy Metabolism and Kinetic Properties of Cytochrome Oxidase Following Acute Aluminium Phosphide Exposure in Rat Liver. Food Chem. Toxicol. 2010, 48 (1), 53–60. https://doi.org/10.1016/j.fct.2009.09.014.
(164) Ohlsson, L.; Exley, C.; Darabi, A.; Sandén, E.; Siesjö, P.; Eriksson, H. Aluminium Based Adjuvants and Their Effects on Mitochondria and Lysosomes of Phagocytosing Cells. J. Inorg. Biochem. 2013, 128, 229–236. https://doi.org/10.1016/j.jinorgbio.2013.08.003.
(165) Iglesias-González, J.; Sánchez-Iglesias, S.; Beiras-Iglesias, A.; Méndez-Álvarez, E.; Soto-Otero, R. Effects of Aluminium on Rat Brain Mitochondria Bioenergetics: An In Vitro and In Vivo Study. Mol. Neurobiol. 2017, 54 (1), 563–570. https://doi.org/10.1007/s12035-015-9650-z.
(166) Arab-Nozari, M.; Zamani, E.; Latifi, A.; Shaki, F. Mitochondrial Toxicity of Aluminium Nanoparticles in Comparison to Its Ionic Form on Isolated Rat Brain Mitochondria. Bratisl Lek Listy 2019, 120 (7), 516–522. https://doi.org/10.4149/BLL_2019_083.
(167) Swegert, C. V.; Dave, K. R.; Katyare, S. S. Effect of Aluminium-Induced Alzheimer like Condition on Oxidative Energy Metabolism in Rat Liver, Brain and Heart Mitochondria. Mech. Ageing Dev. 1999, 112 (1), 27–42. https://doi.org/10.1016/s0047-6374(99)00051-2.
(168) Larsen, P. A.; Lutz, M. W.; Hunnicutt, K. E.; Mihovilovic, M.; Saunders, A. M.; Yoder, A. D.; Roses, A. D. The Alu Neurodegeneration Hypothesis: A Primate-Specific Mechanism for Neuronal Transcription Noise, Mitochondrial Dysfunction, and Manifestation of Neurodegenerative Disease. Alzheimers Dement 2017, 13 (7), 828–838. https://doi.org/10.1016/j.jalz.2017.01.017.
(169) Suzuki, S.; Arnold, L. L.; Muirhead, D.; Lu, X.; Le, X. C.; Bjork, J. A.; Wallace, K. B.; Ohnishi, T.; Kakiuchi-Kiyota, S.; Pennington, K. L.; Cohen, S. M. Inorganic Arsenic-Induced Intramitochondrial Granules in Mouse Urothelium. Toxicol Pathol 2008, 36 (7), 999–1005. https://doi.org/10.1177/0192623308327408.
(170) Gobe, G.; Crane, D. Mitochondria, Reactive Oxygen Species and Cadmium Toxicity in the Kidney. Toxicol. Lett. 2010, 198 (1), 49–55. https://doi.org/10.1016/j.toxlet.2010.04.013.
(171) Mao, W. P.; Zhang, N. N.; Zhou, F. Y.; Li, W. X.; Liu, H. Y.; Feng, J.; Zhou, L.; Wei, C. J.; Pan, Y. B.; He, Z. J. Cadmium Directly Induced Mitochondrial Dysfunction of Human Embryonic Kidney Cells. Hum Exp Toxicol 2011, 30 (8), 920–929. https://doi.org/10.1177/0960327110384286.
(172) Okoye, C. N.; MacDonald-Jay, N.; Kamunde, C. Effects of Bioenergetics, Temperature and Cadmium on Liver Mitochondria Reactive Oxygen Species Production and Consumption. Aquat. Toxicol. 2019, 214, 105264. https://doi.org/10.1016/j.aquatox.2019.105264.
(173) Ashok, I.; Sheeladevi, R. Biochemical Responses and Mitochondrial Mediated Activation of Apoptosis on Long-Term Effect of Aspartame in Rat Brain. Redox Biol 2014, 2, 820–831. https://doi.org/10.1016/j.redox.2014.04.011.
(174) Qu, D.; Jiang, M.; Huang, D.; Zhang, H.; Feng, L.; Chen, Y.; Zhu, X.; Wang, S.; Han, J. Synergistic Effects of The Enhancements to Mitochondrial ROS, P53 Activation and Apoptosis Generated by Aspartame and Potassium Sorbate in HepG2 Cells. Molecules 2019, 24 (3). https://doi.org/10.3390/molecules24030457.
(175) Singh, R. K.; Ishikawa, S. Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver Dysfunction. SOJ Microbiol Infect Dis 2016, 4 (1).
(176) Melnick, R. L.; Schiller, C. M. Mitochondrial Toxicity of Phthalate Esters. Environ. Health Perspect. 1982, 45, 51–56. https://doi.org/10.1289/ehp.824551.
(177) Lu, Y.; Wang, Y.-Y.; Yang, N.; Zhang, D.; Zhang, F.-Y.; Gao, H.-T.; Rong, W.-T.; Yu, S.-Q.; Xu, Q. Food Emulsifier Polysorbate 80 Increases Intestinal Absorption of Di-(2-Ethylhexyl) Phthalate in Rats. Toxicol. Sci. 2014, 139 (2), 317–327. https://doi.org/10.1093/toxsci/kfu055.
(178) Moon, M. K.; Kim, M. J.; Jung, I. K.; Koo, Y. D.; Ann, H. Y.; Lee, K. J.; Kim, S. H.; Yoon, Y. C.; Cho, B.-J.; Park, K. S.; Jang, H. C.; Park, Y. J. Bisphenol A Impairs Mitochondrial Function in the Liver at Doses below the No Observed Adverse Effect Level. J. Korean Med. Sci. 2012, 27 (6), 644–652. https://doi.org/10.3346/jkms.2012.27.6.644.
(179) Qu, W.; Zhao, Z.; Chen, S.; Zhang, L.; Wu, D.; Chen, Z. Bisphenol A Suppresses Proliferation and Induces Apoptosis in Colonic Epithelial Cells through Mitochondrial and MAPK/AKT Pathways. Life Sci. 2018, 208, 167–174. https://doi.org/10.1016/j.lfs.2018.07.040.
(180) Wang, K.; Zhao, Z.; Ji, W. Bisphenol A Induces Apoptosis, Oxidative Stress and Inflammatory Response in Colon and Liver of Mice in a Mitochondria-Dependent Manner. Biomed. Pharmacother. 2019, 117, 109182. https://doi.org/10.1016/j.biopha.2019.109182.
(181) Zhao, Z.; Qu, W.; Wang, K.; Chen, S.; Zhang, L.; Wu, D.; Chen, Z. Bisphenol A Inhibits Mucin 2 Secretion in Intestinal Goblet Cells through Mitochondrial Dysfunction and Oxidative Stress. Biomed. Pharmacother. 2019, 111, 901–908. https://doi.org/10.1016/j.biopha.2019.01.007.
(182) Xu, J.; Huang, G.; Guo, T. L. Developmental Bisphenol A Exposure Modulates Immune-Related Diseases. Toxics 2016, 4 (4). https://doi.org/10.3390/toxics4040023.
(183) Biswas, G.; Srinivasan, S.; Anandatheerthavarada, H. K.; Avadhani, N. G. Dioxin-Mediated Tumor Progression through Activation of Mitochondria-to-Nucleus Stress Signaling. Proc Natl Acad Sci U S A 2008, 105 (1), 186–191. https://doi.org/10.1073/pnas.0706183104.
(184) Hwang, H. J.; Dornbos, P.; Steidemann, M.; Dunivin, T. K.; Rizzo, M.; LaPres, J. J. Mitochondrial-Targeted Aryl Hydrocarbon Receptor and the Impact of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on Cellular Respiration and the Mitochondrial Proteome. Toxicology and Applied Pharmacology 2016, 304, 121–132. https://doi.org/10.1016/j.taap.2016.04.005.
(185) Shen, K.; Shen, C.; Yu, J.; Yu, C.; Chen, L.; Shi, D.; Chen, Y. PCB Congeners Induced Mitochondrial Dysfunction in Vero Cells. J. Hazard. Mater. 2011, 185 (1), 24–28. https://doi.org/10.1016/j.jhazmat.2010.08.061.
(186) Cocco, S.; Secondo, A.; Del Viscovo, A.; Procaccini, C.; Formisano, L.; Franco, C.; Esposito, A.; Scorziello, A.; Matarese, G.; Di Renzo, G.; Canzoniero, L. M. T. Polychlorinated Biphenyls Induce Mitochondrial Dysfunction in SH-SY5Y Neuroblastoma Cells. PLoS One 2015, 10 (6). https://doi.org/10.1371/journal.pone.0129481.
(187) Hoek, J. B.; Cahill, A.; Pastorino, J. G. Alcohol and Mitochondria: A Dysfunctional Relationship. Gastroenterology 2002, 122 (7), 2049–2063. https://doi.org/10.1053/gast.2002.33613.
(188) Manzo-Avalos, S.; Saavedra-Molina, A. Cellular and Mitochondrial Effects of Alcohol Consumption. Int J Environ Res Public Health 2010, 7 (12), 4281–4304. https://doi.org/10.3390/ijerph7124281.
(189) Agarwal, D. P. Genetic Polymorphisms of Alcohol Metabolizing Enzymes. Pathol. Biol. 2001, 49 (9), 703–709. https://doi.org/10.1016/s0369-8114(01)00242-5.
(190) George, A.; Figueredo, V. M. Alcohol and Arrhythmias: A Comprehensive Review. J Cardiovasc Med (Hagerstown) 2010, 11 (4), 221–228. https://doi.org/10.2459/JCM.0b013e328334b42d.
(191) Mansouri, A.; Demeilliers, C.; Amsellem, S.; Pessayre, D.; Fromenty, B. Acute Ethanol Administration Oxidatively Damages and Depletes Mitochondrial Dna in Mouse Liver, Brain, Heart, and Skeletal Muscles: Protective Effects of Antioxidants. J. Pharmacol. Exp. Ther. 2001, 298 (2), 737–743.
(192) Piano, M. R. Alcohol’s Effects on the Cardiovascular System. Alcohol Res 2017, 38 (2), 219–241.
(193) Bukiya, A. N. Fetal Cerebral Artery Mitochondrion as Target of Prenatal Alcohol Exposure. Int J Environ Res Public Health 2019, 16 (9). https://doi.org/10.3390/ijerph16091586.
(194) Tapia-Rojas, C.; Mira, R. G.; Torres, A. K.; Jara, C.; Pérez, M. J.; Vergara, E. H.; Cerpa, W.; Quintanilla, R. A. Alcohol Consumption during Adolescence: A Link between Mitochondrial Damage and Ethanol Brain Intoxication. Birth Defects Res 2017, 109 (20), 1623–1639. https://doi.org/10.1002/bdr2.1172.
(195) Lanza, I. R.; Short, D. K.; Short, K. R.; Raghavakaimal, S.; Basu, R.; Joyner, M. J.; McConnell, J. P.; Nair, K. S. Endurance Exercise as a Countermeasure for Aging. Diabetes 2008, 57 (11), 2933–2942. https://doi.org/10.2337/db08-0349.
(196) Joseph, A.-M.; Adhihetty, P. J.; Buford, T. W.; Wohlgemuth, S. E.; Lees, H. A.; Nguyen, L. M.-D.; Aranda, J. M.; Sandesara, B. D.; Pahor, M.; Manini, T. M.; Marzetti, E.; Leeuwenburgh, C. The Impact of Aging on Mitochondrial Function and Biogenesis Pathways in Skeletal Muscle of Sedentary High- and Low-Functioning Elderly Individuals. Aging Cell 2012, 11 (5), 801–809. https://doi.org/10.1111/j.1474-9726.2012.00844.x.
(197) Macinnis, M.; Gibala, M. Physiological Adaptations to Interval Training and the Role of Exercise Intensity. The Journal of Physiology 2016, 595. https://doi.org/10.1113/JP273196.
(198) Memme, J. M.; Erlich, A. T.; Phukan, G.; Hood, D. A. Exercise and Mitochondrial Health. J. Physiol. (Lond.) 2019. https://doi.org/10.1113/JP278853.
(199) Gradari, S.; Pallé, A.; McGreevy, K. R.; Fontán-Lozano, Á.; Trejo, J. L. Can Exercise Make You Smarter, Happier, and Have More Neurons? A Hormetic Perspective. Front Neurosci 2016, 10, 93. https://doi.org/10.3389/fnins.2016.00093.
(200) Chomentowski, P.; Dubé, J. J.; Amati, F.; Stefanovic-Racic, M.; Zhu, S.; Toledo, F. G. S.; Goodpaster, B. H. Moderate Exercise Attenuates the Loss of Skeletal Muscle Mass That Occurs with Intentional Caloric Restriction-Induced Weight Loss in Older, Overweight to Obese Adults. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64 (5), 575–580. https://doi.org/10.1093/gerona/glp007.
(201) Zhang, J.; Ma, J.; Wang, G.-F. Effects of long-term sleep deprivation on mitochondria stress in locus coeruleus and the tyrosine hydroxylasic projection in mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2014, 30 (2), 153–156.
(202) Weir, H. J. M.; Murray, T. K.; Kehoe, P. G.; Love, S.; Verdin, E. M.; O’Neill, M. J.; Lane, J. D.; Balthasar, N. CNS SIRT3 Expression Is Altered by Reactive Oxygen Species and in Alzheimer’s Disease. PLoS One 2012, 7 (11). https://doi.org/10.1371/journal.pone.0048225.
(203) Nogueiras, R.; Habegger, K. M.; Chaudhary, N.; Finan, B.; Banks, A. S.; Dietrich, M. O.; Horvath, T. L.; Sinclair, D. A.; Pfluger, P. T.; Tschöop, M. H. Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism. Physiol Rev 2012, 92 (3), 1479–1514. https://doi.org/10.1152/physrev.00022.2011.
(204) Lucas, R. J.; Lall, G. S.; Allen, A. E.; Brown, T. M. How Rod, Cone, and Melanopsin Photoreceptors Come Together to Enlighten the Mammalian Circadian Clock. Prog. Brain Res. 2012, 199, 1–18. https://doi.org/10.1016/B978-0-444-59427-3.00001-0.
(205) Peres, M. F. P.; Zukerman, E.; da Cunha Tanuri, F.; Moreira, F. R.; Cipolla-Neto, J. Melatonin, 3 Mg, Is Effective for Migraine Prevention. Neurology 2004, 63 (4), 757. https://doi.org/10.1212/01.wnl.0000134653.35587.24.
(206) Ulugol, A.; Dokmeci, D.; Guray, G.; Sapolyo, N.; Ozyigit, F.; Tamer, M. Antihyperalgesic, but Not Antiallodynic, Effect of Melatonin in Nerve-Injured Neuropathic Mice: Possible Involvements of the L-Arginine-NO Pathway and Opioid System. Life Sci. 2006, 78 (14), 1592–1597. https://doi.org/10.1016/j.lfs.2005.07.002.
(207) Pringsheim, T.; Magnoux, E.; Dobson, C. F.; Hamel, E.; Aubé, M. Melatonin as Adjunctive Therapy in the Prophylaxis of Cluster Headache: A Pilot Study. Headache 2002, 42 (8), 787–792. https://doi.org/10.1046/j.1526-4610.2002.02181.x.
(208) Medrano-Campillo, P.; Sarmiento-Soto, H.; Álvarez-Sánchez, N.; Álvarez-Ríos, A. I.; Guerrero, J. M.; Rodríguez-Prieto, I.; Castillo-Palma, M. J.; Lardone, P. J.; Carrillo-Vico, A. Evaluation of the Immunomodulatory Effect of Melatonin on the T-Cell Response in Peripheral Blood from Systemic Lupus Erythematosus Patients. J. Pineal Res. 2015, 58 (2), 219–226. https://doi.org/10.1111/jpi.12208.
(209) Sanchez-Barcelo, E. J.; Rueda, N.; Mediavilla, M. D.; Martinez-Cue, C.; Reiter, R. J. Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders. Curr. Med. Chem. 2017, 24 (35), 3851–3878. https://doi.org/10.2174/0929867324666170718105557.
(210) Weishaupt, J. H.; Bartels, C.; Pölking, E.; Dietrich, J.; Rohde, G.; Poeggeler, B.; Mertens, N.; Sperling, S.; Bohn, M.; Hüther, G.; Schneider, A.; Bach, A.; Sirén, A.-L.; Hardeland, R.; Bähr, M.; Nave, K.-A.; Ehrenreich, H. Reduced Oxidative Damage in ALS by High-Dose Enteral Melatonin Treatment. J. Pineal Res. 2006, 41 (4), 313–323. https://doi.org/10.1111/j.1600-079X.2006.00377.x.
(211) English, J.; Bojkowski, C. J.; Poulton, A. L.; Symons, A. M.; Arendt, J. Metabolism and Pharmacokinetics of Melatonin in the Ewe. J. Pineal Res. 1987, 4 (4), 351–358. https://doi.org/10.1111/j.1600-079x.1987.tb00874.x.
(212) Iguchi, H.; Kato, K. I.; Ibayashi, H. Melatonin Serum Levels and Metabolic Clearance Rate in Patients with Liver Cirrhosis. J. Clin. Endocrinol. Metab. 1982, 54 (5), 1025–1027. https://doi.org/10.1210/jcem-54-5-1025.
(213) Wade, A. G.; Ford, I.; Crawford, G.; McMahon, A. D.; Nir, T.; Laudon, M.; Zisapel, N. Efficacy of Prolonged Release Melatonin in Insomnia Patients Aged 55-80 Years: Quality of Sleep and next-Day Alertness Outcomes. Curr Med Res Opin 2007, 23 (10), 2597–2605. https://doi.org/10.1185/030079907X233098.
(214) Luthringer, R.; Muzet, M.; Zisapel, N.; Staner, L. The Effect of Prolonged-Release Melatonin on Sleep Measures and Psychomotor Performance in Elderly Patients with Insomnia. Int Clin Psychopharmacol 2009, 24 (5), 239–249. https://doi.org/10.1097/YIC.0b013e32832e9b08.
(215) Claustrat, B.; Brun, J.; Chazot, G. The Basic Physiology and Pathophysiology of Melatonin. Sleep Med Rev 2005, 9 (1), 11–24. https://doi.org/10.1016/j.smrv.2004.08.001.
(216) Lemoine, P.; Nir, T.; Laudon, M.; Zisapel, N. Prolonged-Release Melatonin Improves Sleep Quality and Morning Alertness in Insomnia Patients Aged 55 Years and Older and Has No Withdrawal Effects. J Sleep Res 2007, 16 (4), 372–380. https://doi.org/10.1111/j.1365-2869.2007.00613.x.
(217) Picard, M.; McEwen, B. S. Psychological Stress and Mitochondria: A Systematic Review. Psychosom Med 2018, 80 (2), 141–153. https://doi.org/10.1097/PSY.0000000000000545.
(218) Picard, M.; McEwen, B. S. Psychological Stress and Mitochondria: A Conceptual Framework. Psychosom Med 2018, 80 (2), 126–140. https://doi.org/10.1097/PSY.0000000000000544.
(219) Picard, M.; Juster, R.-P.; McEwen, B. S. Mitochondrial Allostatic Load Puts the “gluc” Back in Glucocorticoids. Nat Rev Endocrinol 2014, 10 (5), 303–310. https://doi.org/10.1038/nrendo.2014.22.
(220) Markham, A.; Bains, R.; Franklin, P.; Spedding, M. Changes in Mitochondrial Function Are Pivotal in Neurodegenerative and Psychiatric Disorders: How Important Is BDNF? Br. J. Pharmacol. 2014, 171 (8), 2206–2229. https://doi.org/10.1111/bph.12531.
(221) Bose, H. S.; Lingappa, V. R.; Miller, W. L. Rapid Regulation of Steroidogenesis by Mitochondrial Protein Import. Nature 2002, 417 (6884), 87–91. https://doi.org/10.1038/417087a.
(222) Midzak, A.; Papadopoulos, V. Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies. Front Endocrinol (Lausanne) 2016, 7, 106. https://doi.org/10.3389/fendo.2016.00106.
(223) Inczedy-Farkas, G.; Remenyi, V.; Gal, A.; Varga, Z.; Balla, P.; Udvardy-Meszaros, A.; Bereznai, B.; Molnar, M. J. Psychiatric Symptoms of Patients with Primary Mitochondrial DNA Disorders. Behav Brain Funct 2012, 8, 9. https://doi.org/10.1186/1744-9081-8-9.
(224) Toker, L.; Agam, G. Mitochondrial Dysfunction in Psychiatric Morbidity: Current Evidence and Therapeutic Prospects. Neuropsychiatr Dis Treat 2015, 11, 2441–2447. https://doi.org/10.2147/NDT.S70346.
(225) Manji, H.; Kato, T.; Di Prospero, N. A.; Ness, S.; Beal, M. F.; Krams, M.; Chen, G. Impaired Mitochondrial Function in Psychiatric Disorders. Nat. Rev. Neurosci. 2012, 13 (5), 293–307. https://doi.org/10.1038/nrn3229.
(226) Gardner, A.; Boles, R. G. Beyond the Serotonin Hypothesis: Mitochondria, Inflammation and Neurodegeneration in Major Depression and Affective Spectrum Disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35 (3), 730–743. https://doi.org/10.1016/j.pnpbp.2010.07.030.
(227) Kaplan, B. The Emerging Field of Nutritional Mental Health: Inflammation, the Microbiome, Oxidative Stress, and Mitochondrial Function. Clnical Psychological Science 2015. https://doi.org/10.1177/2167702614555413.
(228) Morris, G.; Berk, M. The Many Roads to Mitochondrial Dysfunction in Neuroimmune and Neuropsychiatric Disorders. BMC Med 2015, 13, 68. https://doi.org/10.1186/s12916-015-0310-y.
(229) Picard, M.; McManus, M. J.; Gray, J. D.; Nasca, C.; Moffat, C.; Kopinski, P. K.; Seifert, E. L.; McEwen, B. S.; Wallace, D. C. Mitochondrial Functions Modulate Neuroendocrine, Metabolic, Inflammatory, and Transcriptional Responses to Acute Psychological Stress. Proc. Natl. Acad. Sci. U.S.A. 2015, 112 (48), E6614-6623. https://doi.org/10.1073/pnas.1515733112.
(230) Valenti, D.; de Bari, L.; De Filippis, B.; Henrion-Caude, A.; Vacca, R. A. Mitochondrial Dysfunction as a Central Actor in Intellectual Disability-Related Diseases: An Overview of Down Syndrome, Autism, Fragile X and Rett Syndrome. Neurosci Biobehav Rev 2014, 46 Pt 2, 202–217. https://doi.org/10.1016/j.neubiorev.2014.01.012.
(231) Bhasin, M. K.; Dusek, J. A.; Chang, B.-H.; Joseph, M. G.; Denninger, J. W.; Fricchione, G. L.; Benson, H.; Libermann, T. A. Relaxation Response Induces Temporal Transcriptome Changes in Energy Metabolism, Insulin Secretion and Inflammatory Pathways. PLoS ONE 2013, 8 (5), e62817. https://doi.org/10.1371/journal.pone.0062817.
(232) Kim, J.-H.; Kim, H. K.; Ko, J.-H.; Bang, H.; Lee, D.-C. The Relationship between Leukocyte Mitochondrial DNA Copy Number and Telomere Length in Community-Dwelling Elderly Women. PLoS ONE 2013, 8 (6), e67227. https://doi.org/10.1371/journal.pone.0067227.
(233) Wang, H.; Olivero, W.; Wang, D.; Lanzino, G. Cold as a Therapeutic Agent. Acta Neurochir (Wien) 2006, 148 (5), 565–570; discussion 569-570. https://doi.org/10.1007/s00701-006-0747-z.
(234) Auer, R. N. Non-Pharmacologic (Physiologic) Neuroprotection in the Treatment of Brain Ischemia. Ann. N. Y. Acad. Sci. 2001, 939, 271–282. https://doi.org/10.1111/j.1749-6632.2001.tb03635.x.
(235) Hayashi, N.; Dietrich, D. W. Brain Hypothermia Treatment; Springer Japan, 2004. https://doi.org/10.1007/978-4-431-53953-7.
(236) Weglinski, M. R. Therapeutic Hypothermia. Anesthesiology 2005, 103 (3), 673–674.
(237) Polderman, K. H. Induced Hypothermia and Fever Control for Prevention and Treatment of Neurological Injuries. Lancet 2008, 371 (9628), 1955–1969. https://doi.org/10.1016/S0140-6736(08)60837-5.
(238) Polderman, K. H.; Herold, I. Therapeutic Hypothermia and Controlled Normothermia in the Intensive Care Unit: Practical Considerations, Side Effects, and Cooling Methods. Crit. Care Med. 2009, 37 (3), 1101–1120. https://doi.org/10.1097/CCM.0b013e3181962ad5.
(239) Polderman, K. Mechanisms of Action, Physiological Effects, and Complications of Hypothermia. Critical care medicine 2009, 37, S186-202. https://doi.org/10.1097/CCM.0b013e3181aa5241.
(240) Bernard, S. A.; Gray, T. W.; Buist, M. D.; Jones, B. M.; Silvester, W.; Gutteridge, G.; Smith, K. Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia. N. Engl. J. Med. 2002, 346 (8), 557–563. https://doi.org/10.1056/NEJMoa003289.
(241) Hypothermia after Cardiac Arrest Study Group. Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest. N. Engl. J. Med. 2002, 346 (8), 549–556. https://doi.org/10.1056/NEJMoa012689.
(242) Eicher, D. J.; Wagner, C. L.; Katikaneni, L. P.; Hulsey, T. C.; Bass, W. T.; Kaufman, D. A.; Horgan, M. J.; Languani, S.; Bhatia, J. J.; Givelichian, L. M.; Sankaran, K.; Yager, J. Y. Moderate Hypothermia in Neonatal Encephalopathy: Efficacy Outcomes. Pediatr. Neurol. 2005, 32 (1), 11–17. https://doi.org/10.1016/j.pediatrneurol.2004.06.014.
(243) Gluckman, P. D.; Wyatt, J. S.; Azzopardi, D.; Ballard, R.; Edwards, A. D.; Ferriero, D. M.; Polin, R. A.; Robertson, C. M.; Thoresen, M.; Whitelaw, A.; Gunn, A. J. Selective Head Cooling with Mild Systemic Hypothermia after Neonatal Encephalopathy: Multicentre Randomised Trial. Lancet 2005, 365 (9460), 663–670. https://doi.org/10.1016/S0140-6736(05)17946-X.
(244) Shankaran, S.; Laptook, A. R.; Ehrenkranz, R. A.; Tyson, J. E.; McDonald, S. A.; Donovan, E. F.; Fanaroff, A. A.; Poole, W. K.; Wright, L. L.; Higgins, R. D.; Finer, N. N.; Carlo, W. A.; Duara, S.; Oh, W.; Cotten, C. M.; Stevenson, D. K.; Stoll, B. J.; Lemons, J. A.; Guillet, R.; Jobe, A. H.; National Institute of Child Health and Human Development Neonatal Research Network. Whole-Body Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy. N. Engl. J. Med. 2005, 353 (15), 1574–1584. https://doi.org/10.1056/NEJMcps050929.
(245) Shiozaki, T.; Hayakata, T.; Taneda, M.; Nakajima, Y.; Hashiguchi, N.; Fujimi, S.; Nakamori, Y.; Tanaka, H.; Shimazu, T.; Sugimoto, H. A Multicenter Prospective Randomized Controlled Trial of the Efficacy of Mild Hypothermia for Severely Head Injured Patients with Low Intracranial Pressure. Mild Hypothermia Study Group in Japan. J. Neurosurg. 2001, 94 (1), 50–54. https://doi.org/10.3171/jns.2001.94.1.0050.
(246) McIntyre, L. A.; Fergusson, D. A.; Hébert, P. C.; Moher, D.; Hutchison, J. S. Prolonged Therapeutic Hypothermia after Traumatic Brain Injury in Adults: A Systematic Review. JAMA 2003, 289 (22), 2992–2999. https://doi.org/10.1001/jama.289.22.2992.
(247) Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS; Bratton, S. L.; Chestnut, R. M.; Ghajar, J.; McConnell Hammond, F. F.; Harris, O. A.; Hartl, R.; Manley, G. T.; Nemecek, A.; Newell, D. W.; Rosenthal, G.; Schouten, J.; Shutter, L.; Timmons, S. D.; Ullman, J. S.; Videtta, W.; Wilberger, J. E.; Wright, D. W. Guidelines for the Management of Severe Traumatic Brain Injury. XIV. Hyperventilation. J. Neurotrauma 2007, 24 Suppl 1, S87-90. https://doi.org/10.1089/neu.2007.9982.
(248) Tong, G.; Krauss, A.; Mochner, J.; Wollersheim, S.; Soltani, P.; Berger, F.; Schmitt, K. R. L. Deep Hypothermia Therapy Attenuates LPS-Induced Microglia Neuroinflammation via the STAT3 Pathway. Neuroscience 2017, 358, 201–210. https://doi.org/10.1016/j.neuroscience.2017.06.055.
(249) Kuter, N.; Aysit-Altuncu, N.; Ozturk, G.; Ozek, E. The Neuroprotective Effects of Hypothermia on Bilirubin-Induced Neurotoxicity in Vitro. Neonatology 2018, 113 (4), 360–365. https://doi.org/10.1159/000487221.
(250) Barnes, B. M. Freeze Avoidance in a Mammal: Body Temperatures below 0 Degree C in an Arctic Hibernator. Science 1989, 244 (4912), 1593–1595. https://doi.org/10.1126/science.2740905.
(251) Bickler, P. E.; Buck, L. T. Hypoxia Tolerance in Reptiles, Amphibians, and Fishes: Life with Variable Oxygen Availability. Annu. Rev. Physiol. 2007, 69, 145–170. https://doi.org/10.1146/annurev.physiol.69.031905.162529.
(252) Peterson, B. L.; Larson, J.; Buffenstein, R.; Park, T. J.; Fall, C. P. Blunted Neuronal Calcium Response to Hypoxia in Naked Mole-Rat Hippocampus. PLoS ONE 2012, 7 (2), e31568. https://doi.org/10.1371/journal.pone.0031568.
(253) Larson, J.; Drew, K. L.; Folkow, L. P.; Milton, S. L.; Park, T. J. No Oxygen? No Problem! Intrinsic Brain Tolerance to Hypoxia in Vertebrates. J. Exp. Biol. 2014, 217 (Pt 7), 1024–1039. https://doi.org/10.1242/jeb.085381.
(254) Ali, S. S.; Hsiao, M.; Zhao, H. W.; Dugan, L. L.; Haddad, G. G.; Zhou, D. Hypoxia-Adaptation Involves Mitochondrial Metabolic Depression and Decreased ROS Leakage. PLoS ONE 2012, 7 (5), e36801. https://doi.org/10.1371/journal.pone.0036801.
(255) Hogg, D. W.; Pamenter, M. E.; Dukoff, D. J.; Buck, L. T. Decreases in Mitochondrial Reactive Oxygen Species Initiate GABA(A) Receptor-Mediated Electrical Suppression in Anoxia-Tolerant Turtle Neurons. J. Physiol. (Lond.) 2015, 593 (10), 2311–2326. https://doi.org/10.1113/JP270474.
(256) Pamenter, M. E.; Gomez, C. R.; Richards, J. G.; Milsom, W. K. Mitochondrial Responses to Prolonged Anoxia in Brain of Red-Eared Slider Turtles. Biol Lett 2016, 12 (1). https://doi.org/10.1098/rsbl.2015.0797.
(257) Prabhakar, N. R.; Semenza, G. L. Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2. Physiol. Rev. 2012, 92 (3), 967–1003. https://doi.org/10.1152/physrev.00030.2011.
(258) Beall, C. M.; Brittenham, G. M.; Strohl, K. P.; Blangero, J.; Williams-Blangero, S.; Goldstein, M. C.; Decker, M. J.; Vargas, E.; Villena, M.; Soria, R.; Alarcon, A. M.; Gonzales, C. Hemoglobin Concentration of High-Altitude Tibetans and Bolivian Aymara. Am. J. Phys. Anthropol. 1998, 106 (3), 385–400. https://doi.org/10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.0.CO;2-X.
(259) Beall, C. M.; Decker, M. J.; Brittenham, G. M.; Kushner, I.; Gebremedhin, A.; Strohl, K. P. An Ethiopian Pattern of Human Adaptation to High-Altitude Hypoxia. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (26), 17215–17218. https://doi.org/10.1073/pnas.252649199.
(260) Yin, H.; Blanchard, K. L. DNA Methylation Represses the Expression of the Human Erythropoietin Gene by Two Different Mechanisms. Blood 2000, 95 (1), 111–119.
(261) Ouellet, V.; Labbé, S. M.; Blondin, D. P.; Phoenix, S.; Guérin, B.; Haman, F.; Turcotte, E. E.; Richard, D.; Carpentier, A. C. Brown Adipose Tissue Oxidative Metabolism Contributes to Energy Expenditure during Acute Cold Exposure in Humans. J Clin Invest 2012, 122 (2), 545–552. https://doi.org/10.1172/JCI60433.
(262) Cypess, A. M.; Chen, Y.-C.; Sze, C.; Wang, K.; English, J.; Chan, O.; Holman, A. R.; Tal, I.; Palmer, M. R.; Kolodny, G. M.; Kahn, C. R. Cold but Not Sympathomimetics Activates Human Brown Adipose Tissue in Vivo. PNAS 2012, 109 (25), 10001–10005. https://doi.org/10.1073/pnas.1207911109.
(263) Lichtenbelt, W. van M.; Kingma, B.; van der Lans, A.; Schellen, L. Cold Exposure–an Approach to Increasing Energy Expenditure in Humans. Trends Endocrinol. Metab. 2014, 25 (4), 165–167. https://doi.org/10.1016/j.tem.2014.01.001.
(264) Koska, J.; Ksinantova, L.; Seböková, E.; Kvetnansky, R.; Klimes, I.; Chrousos, G.; Pacak, K. Endocrine Regulation of Subcutaneous Fat Metabolism during Cold Exposure in Humans. Ann. N. Y. Acad. Sci. 2002, 967, 500–505. https://doi.org/10.1111/j.1749-6632.2002.tb04308.x.
(265) Shibata, R.; Ouchi, N.; Murohara, T. Adiponectin and Cardiovascular Disease. Circ. J. 2009, 73 (4), 608–614. https://doi.org/10.1253/circj.cj-09-0057.
(266) Imbeault, P.; Dépault, I.; Haman, F. Cold Exposure Increases Adiponectin Levels in Men. Metab. Clin. Exp. 2009, 58 (4), 552–559. https://doi.org/10.1016/j.metabol.2008.11.017.
(267) Janský, L.; Pospísilová, D.; Honzová, S.; Ulicný, B.; Srámek, P.; Zeman, V.; Kamínková, J. Immune System of Cold-Exposed and Cold-Adapted Humans. Eur J Appl Physiol Occup Physiol 1996, 72 (5–6), 445–450. https://doi.org/10.1007/BF00242274.
(268) Girotti, M.; Donegan, J. J.; Morilak, D. A. Chronic Intermittent Cold Stress Sensitizes Neuro-Immune Reactivity in the Rat Brain. Psychoneuroendocrinology 2011, 36 (8), 1164–1174. https://doi.org/10.1016/j.psyneuen.2011.02.008.
(269) Girotti, M.; Donegan, J. J.; Morilak, D. A. Influence of Hypothalamic IL-6/Gp130 Receptor Signaling on the HPA Axis Response to Chronic Stress. Psychoneuroendocrinology 2013, 38 (7), 1158–1169. https://doi.org/10.1016/j.psyneuen.2012.11.004.
(270) Gagnon, D. D.; Gagnon, S. S.; Rintamäki, H.; Törmäkangas, T.; Puukka, K.; Herzig, K.-H.; Kyröläinen, H. The Effects of Cold Exposure on Leukocytes, Hormones and Cytokines during Acute Exercise in Humans. PLOS ONE 2014, 9 (10), e110774. https://doi.org/10.1371/journal.pone.0110774.
(271) Black, D. S.; Slavich, G. M. Mindfulness Meditation and the Immune System: A Systematic Review of Randomized Controlled Trials. Ann N Y Acad Sci 2016, 1373 (1), 13–24. https://doi.org/10.1111/nyas.12998.
(272) Thieringer, H. A.; Jones, P. G.; Inouye, M. Cold Shock and Adaptation. Bioessays 1998, 20 (1), 49–57. https://doi.org/10.1002/(SICI)1521-1878(199801)20:1<49::AID-BIES8>3.0.CO;2-N.
(273) Eglin, C. M.; Butt, G.; Howden, S.; Nash, T.; Costello, J. Rapid Habituation of the Cold Shock Response. Extrem Physiol Med 2015, 4 (Suppl 1), A38. https://doi.org/10.1186/2046-7648-4-S1-A38.
(274) Dorfman, M.; Ramirez, V. D.; Stener-Victorin, E.; Lara, H. E. Chronic-Intermittent Cold Stress in Rats Induces Selective Ovarian Insulin Resistance. Biol. Reprod. 2009, 80 (2), 264–271. https://doi.org/10.1095/biolreprod.108.070904.
(275) Wang, X.; Che, H.; Zhang, W.; Wang, J.; Ke, T.; Cao, R.; Meng, S.; Li, D.; Weiming, O.; Chen, J.; Luo, W. Effects of Mild Chronic Intermittent Cold Exposure on Rat Organs. Int J Biol Sci 2015, 11 (10), 1171–1180. https://doi.org/10.7150/ijbs.12161.
(276) Young, S.; Bolton, P.; Dyson, M.; Harvey, W.; Diamantopoulos, C. Macrophage Responsiveness to Light Therapy. Lasers Surg Med 1989, 9 (5), 497–505. https://doi.org/10.1002/lsm.1900090513.
(277) Lubart, R.; Friedmann, H.; Sinyakov, M.; Cohen, N.; Breitbart, H. Changes in Calcium Transport in Mammalian Sperm Mitochondria and Plasma Membranes Caused by 780 Nm Irradiation. Lasers Surg Med 1997, 21 (5), 493–499. https://doi.org/10.1002/(sici)1096-9101(1997)21:5<493::aid-lsm12>3.0.co;2-a.
(278) Agaiby, A. D.; Ghali, L. R.; Wilson, R.; Dyson, M. Laser Modulation of Angiogenic Factor Production by T-Lymphocytes. Lasers Surg Med 2000, 26 (4), 357–363. https://doi.org/10.1002/(sici)1096-9101(2000)26:4<357::aid-lsm3>3.0.co;2-o.
(279) Duan, R.; Liu, T. C.; Li, Y.; Guo, H.; Yao, L. B. Signal Transduction Pathways Involved in Low Intensity He-Ne Laser-Induced Respiratory Burst in Bovine Neutrophils: A Potential Mechanism of Low Intensity Laser Biostimulation. Lasers Surg Med 2001, 29 (2), 174–178. https://doi.org/10.1002/lsm.1106.
(280) Nussbaum, E. L.; Lilge, L.; Mazzulli, T. Effects of 810 Nm Laser Irradiation on in Vitro Growth of Bacteria: Comparison of Continuous Wave and Frequency Modulated Light. Lasers Surg Med 2002, 31 (5), 343–351. https://doi.org/10.1002/lsm.10121.
(281) Schindl, A.; Heinze, G.; Schindl, M.; Pernerstorfer-Schön, H.; Schindl, L. Systemic Effects of Low-Intensity Laser Irradiation on Skin Microcirculation in Patients with Diabetic Microangiopathy. Microvasc. Res. 2002, 64 (2), 240–246. https://doi.org/10.1006/mvre.2002.2429.
(282) Schindl, A.; Merwald, H.; Schindl, L.; Kaun, C.; Wojta, J. Direct Stimulatory Effect of Low-Intensity 670 Nm Laser Irradiation on Human Endothelial Cell Proliferation. Br. J. Dermatol. 2003, 148 (2), 334–336. https://doi.org/10.1046/j.1365-2133.2003.05070.x.
(283) Borzabadi-Farahani, A. Effect of Low-Level Laser Irradiation on Proliferation of Human Dental Mesenchymal Stem Cells; a Systemic Review. J. Photochem. Photobiol. B, Biol. 2016, 162, 577–582. https://doi.org/10.1016/j.jphotobiol.2016.07.022.
(284) Karu, T.; Pyatibrat, L.; Kalendo, G. Irradiation with He-Ne Laser Increases ATP Level in Cells Cultivated in Vitro. J. Photochem. Photobiol. B, Biol. 1995, 27 (3), 219–223. https://doi.org/10.1016/1011-1344(94)07078-3.
(285) Pastore, D.; Di Martino, C.; Bosco, G.; Passarella, S. Stimulation of ATP Synthesis via Oxidative Phosphorylation in Wheat Mitochondria Irradiated with Helium-Neon Laser. Biochem. Mol. Biol. Int. 1996, 39 (1), 149–157. https://doi.org/10.1080/15216549600201151.
(286) Karu, T. Primary and Secondary Mechanisms of Action of Visible to Near-IR Radiation on Cells. J. Photochem. Photobiol. B, Biol. 1999, 49 (1), 1–17. https://doi.org/10.1016/S1011-1344(98)00219-X.
(287) Karu, T. I.; Pyatibrat, L. V.; Kalendo, G. S. Cell Attachment to Extracellular Matrices Is Modulated by Pulsed Radiation at 820 Nm and Chemicals That Modify the Activity of Enzymes in the Plasma Membrane. Lasers Surg Med 2001, 29 (3), 274–281. https://doi.org/10.1002/lsm.1119.
(288) Hamblin, M. R. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem. Photobiol. 2018, 94 (2), 199–212. https://doi.org/10.1111/php.12864.
(289) Lima, P. L. V.; Pereira, C. V.; Nissanka, N.; Arguello, T.; Gavini, G.; Maranduba, C. M. da C.; Diaz, F.; Moraes, C. T. Photobiomodulation Enhancement of Cell Proliferation at 660 nm Does Not Require Cytochrome c Oxidase. J. Photochem. Photobiol. B, Biol. 2019, 194, 71–75. https://doi.org/10.1016/j.jphotobiol.2019.03.015.
(290) Slominski, A.; Pawelek, J. Animals under the Sun: Effects of Ultraviolet Radiation on Mammalian Skin. Clin. Dermatol. 1998, 16 (4), 503–515. https://doi.org/10.1016/s0738-081x(98)00023-6.
(291) Karu, T. I.; Pyatibrat, L. V.; Kolyakov, S. F.; Afanasyeva, N. I. Absorption Measurements of a Cell Monolayer Relevant to Phototherapy: Reduction of Cytochrome c Oxidase under near IR Radiation. J. Photochem. Photobiol. B, Biol. 2005, 81 (2), 98–106. https://doi.org/10.1016/j.jphotobiol.2005.07.002.
(292) Tiphlova, O.; Karu, T. Action of Low-Intensity Laser Radiation on Escherichia Coli. Crit Rev Biomed Eng 1991, 18 (6), 387–412.
(293) Morimoto, Y.; Arai, T.; Kikuchi, M.; Nakajima, S.; Nakamura, H. Effect of Low-Intensity Argon Laser Irradiation on Mitochondrial Respiration. Lasers Surg Med 1994, 15 (2), 191–199. https://doi.org/10.1002/lsm.1900150207.
(294) Pastore, D.; Greco, M.; Passarella, S. Specific Helium-Neon Laser Sensitivity of the Purified Cytochrome c Oxidase. Int. J. Radiat. Biol. 2000, 76 (6), 863–870. https://doi.org/10.1080/09553000050029020.
(295) Eells, J. T.; Henry, M. M.; Summerfelt, P.; Wong-Riley, M. T. T.; Buchmann, E. V.; Kane, M.; Whelan, N. T.; Whelan, H. T. Therapeutic Photobiomodulation for Methanol-Induced Retinal Toxicity. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (6), 3439–3444. https://doi.org/10.1073/pnas.0534746100.
(296) Karu, T. I.; Pyatibrat, L. V.; Ryabykh, T. P. Melatonin Modulates the Action of near Infrared Radiation on Cell Adhesion. J. Pineal Res. 2003, 34 (3), 167–172. https://doi.org/10.1034/j.1600-079x.2003.00023.x.
(297) Karu, T. I.; Pyatibrat, L. V.; Kalendo, G. S. Photobiological Modulation of Cell Attachment via Cytochrome c Oxidase. Photochem. Photobiol. Sci. 2004, 3 (2), 211–216. https://doi.org/10.1039/b306126d.
(298) Eells, J. T.; Wong-Riley, M. T. T.; VerHoeve, J.; Henry, M.; Buchman, E. V.; Kane, M. P.; Gould, L. J.; Das, R.; Jett, M.; Hodgson, B. D.; Margolis, D.; Whelan, H. T. Mitochondrial Signal Transduction in Accelerated Wound and Retinal Healing by Near-Infrared Light Therapy. Mitochondrion 2004, 4 (5–6), 559–567. https://doi.org/10.1016/j.mito.2004.07.033.
(299) Wong-Riley, M. T. T.; Liang, H. L.; Eells, J. T.; Chance, B.; Henry, M. M.; Buchmann, E.; Kane, M.; Whelan, H. T. Photobiomodulation Directly Benefits Primary Neurons Functionally Inactivated by Toxins: Role of Cytochrome c Oxidase. J. Biol. Chem. 2005, 280 (6), 4761–4771. https://doi.org/10.1074/jbc.M409650200.
(300) Karu, T. I. Mitochondrial Signaling in Mammalian Cells Activated by Red and Near-IR Radiation. Photochem. Photobiol. 2008, 84 (5), 1091–1099. https://doi.org/10.1111/j.1751-1097.2008.00394.x.
(301) Karu, T.; Pyatibrat, L.; Kalendo, G. Irradiation with He–Ne Laser Can Influence the Cytotoxic Response of HeLa Cells to Ionizing Radiation. Int. J. Radiat. Biol. 1994, 65 (6), 691–697. https://doi.org/10.1080/09553009414550811.
(302) Zhang, Y.; Song, S.; Fong, C.-C.; Tsang, C.-H.; Yang, Z.; Yang, M. CDNA Microarray Analysis of Gene Expression Profiles in Human Fibroblast Cells Irradiated with Red Light. J. Invest. Dermatol. 2003, 120 (5), 849–857. https://doi.org/10.1046/j.1523-1747.2003.12133.x.
(303) Maiya, G. A.; Kumar, P.; Rao, L. Effect of Low Intensity Helium-Neon (He-Ne) Laser Irradiation on Diabetic Wound Healing Dynamics. Photomed Laser Surg 2005, 23 (2), 187–190. https://doi.org/10.1089/pho.2005.23.187.
(304) Alves, A. N.; Fernandes, K. P. S.; Deana, A. M.; Bussadori, S. K.; Mesquita-Ferrari, R. A. Effects of Low-Level Laser Therapy on Skeletal Muscle Repair: A Systematic Review. Am J Phys Med Rehabil 2014, 93 (12), 1073–1085. https://doi.org/10.1097/PHM.0000000000000158.
(305) Yu, S.; Lan, C.-C. E.; Yu, H.-S. Mechanisms of Repigmentation Induced by Photobiomodulation Therapy in Vitiligo. Exp. Dermatol. 2019, 28 Suppl 1, 10–14. https://doi.org/10.1111/exd.13823.
(306) Salehpour, F.; Mahmoudi, J.; Kamari, F.; Sadigh-Eteghad, S.; Rasta, S. H.; Hamblin, M. R. Brain Photobiomodulation Therapy: A Narrative Review. Mol. Neurobiol. 2018, 55 (8), 6601–6636. https://doi.org/10.1007/s12035-017-0852-4.
(307) Hamblin, M. R. Photobiomodulation for Alzheimer’s Disease: Has the Light Dawned? Photonics 2019, 6 (3). https://doi.org/10.3390/photonics6030077.
(308) Huang, Y.-Y.; Gupta, A.; Vecchio, D.; de Arce, V. J. B.; Huang, S.-F.; Xuan, W.; Hamblin, M. R. Transcranial Low Level Laser (Light) Therapy for Traumatic Brain Injury. J Biophotonics 2012, 5 (11–12), 827–837. https://doi.org/10.1002/jbio.201200077.
(309) Hamblin, M. R. Photobiomodulation for Traumatic Brain Injury and Stroke. J. Neurosci. Res. 2018, 96 (4), 731–743. https://doi.org/10.1002/jnr.24190.
(310) Caldieraro, M. A.; Cassano, P. Transcranial and Systemic Photobiomodulation for Major Depressive Disorder: A Systematic Review of Efficacy, Tolerability and Biological Mechanisms. J Affect Disord 2019, 243, 262–273. https://doi.org/10.1016/j.jad.2018.09.048.
(311) Bashardoust Tajali, S.; Macdermid, J. C.; Houghton, P.; Grewal, R. Effects of Low Power Laser Irradiation on Bone Healing in Animals: A Meta-Analysis. J Orthop Surg Res 2010, 5, 1. https://doi.org/10.1186/1749-799X-5-1.
(312) Zein, R.; Selting, W.; Benedicenti, S. Effect of Low-Level Laser Therapy on Bone Regeneration During Osseointegration and Bone Graft. Photomed Laser Surg 2017, 35 (12), 649–658. https://doi.org/10.1089/pho.2017.4275.
(313) Hosseinpour, S.; Fekrazad, R.; Arany, P. R.; Ye, Q. Molecular Impacts of Photobiomodulation on Bone Regeneration: A Systematic Review. Prog. Biophys. Mol. Biol. 2019, 149, 147–159. https://doi.org/10.1016/j.pbiomolbio.2019.04.005.
(314) al-Awami, M.; Schillinger, M.; Maca, T.; Pollanz, S.; Minar, E. Low Level Laser Therapy for Treatment of Primary and Secondary Raynaud’s Phenomenon. VASA 2004, 33 (1), 25–29. https://doi.org/10.1024/0301-1526.33.1.25.
(315) Höfling, D. B.; Chavantes, M. C.; Juliano, A. G.; Cerri, G. G.; Knobel, M.; Yoshimura, E. M.; Chammas, M. C. Low-Level Laser in the Treatment of Patients with Hypothyroidism Induced by Chronic Autoimmune Thyroiditis: A Randomized, Placebo-Controlled Clinical Trial. Lasers Med Sci 2013, 28 (3), 743–753. https://doi.org/10.1007/s10103-012-1129-9.
(316) Morcos, N.; Omran, M.; Ghanem, H.; Elahdal, M.; Kamel, N.; Attia, E. Phototherapeutic Effect of Low-Level Laser on Thyroid Gland of Gamma-Irradiated Rats. Photochem. Photobiol. 2015, 91 (4), 942–951. https://doi.org/10.1111/php.12465.
(317) Höfling, D. B.; Chavantes, M. C.; Buchpiguel, C. A.; Cerri, G. G.; Marui, S.; Carneiro, P. C.; Chammas, M. C. Safety and Efficacy of Low-Level Laser Therapy in Autoimmune Thyroiditis: Long-Term Follow-Up Study. Int J Endocrinol 2018, 2018, 8387530. https://doi.org/10.1155/2018/8387530.
(318) Huang, Z.; Ma, J.; Chen, J.; Shen, B.; Pei, F.; Kraus, V. B. The Effectiveness of Low-Level Laser Therapy for Nonspecific Chronic Low Back Pain: A Systematic Review and Meta-Analysis. Arthritis Res. Ther. 2015, 17, 360. https://doi.org/10.1186/s13075-015-0882-0.
(319) Kisselev, S. B.; Moskvin, S. V. The Use of Laser Therapy for Patients with Fibromyalgia: A Critical Literary Review. J Lasers Med Sci 2019, 10 (1), 12–20. https://doi.org/10.15171/jlms.2019.02.
(320) Bjordal, J. M.; Lopes-Martins, R. A.; Joensen, J.; Couppe, C.; Ljunggren, A. E.; Stergioulas, A.; Johnson, M. I. A Systematic Review with Procedural Assessments and Meta-Analysis of Low Level Laser Therapy in Lateral Elbow Tendinopathy (Tennis Elbow). BMC Musculoskelet Disord 2008, 9, 75. https://doi.org/10.1186/1471-2474-9-75.
(321) Moskvin, S.; Ivanovich Apolikhin, O. Effectiveness of Low Level Laser Therapy for Treating Male Infertility. Biomedicine (Taipei) 2018, 8 (2), 7. https://doi.org/10.1051/bmdcn/2018080207.
(322) Yeste, M.; Castillo-Martín, M.; Bonet, S.; Rodríguez-Gil, J. E. Impact of Light Irradiation on Preservation and Function of Mammalian Spermatozoa. Animal Reproduction Science 2018, 194, 19–32. https://doi.org/10.1016/j.anireprosci.2018.02.004.
(323) Aziz-Jalali, M. H.; Tabaie, S. M.; Djavid, G. E. Comparison of Red and Infrared Low-Level Laser Therapy in the Treatment of Acne Vulgaris. Indian J Dermatol 2012, 57 (2), 128–130. https://doi.org/10.4103/0019-5154.94283.
(324) Darvin, M. E.; Gersonde, I.; Albrecht, H.; Zastrow, L.; Sterry, W.; Lademann, J. In Vivo Raman Spectroscopic Analysis of the Influence of IR Radiation on the Carotenoid Antioxidant Substances Beta-Carotene and Lycopene in the Human Skin. Formation of Free Radicals. Laser Physics Letters 2007, 4 (4), 318–321. https://doi.org/10.1002/lapl.200610113.
(325) Darvin, M.; Zastrov, L.; Gonchukov, S.; Lademann, J. Influence of IR Radiation on the Carotenoid Content in Human Skin. Optics and Spectroscopy 2009, 107, 917–920. https://doi.org/10.1134/S0030400X09120133.
(326) Barolet, D.; Christiaens, F.; Hamblin, M. R. Infrared and Skin: Friend or Foe. J. Photochem. Photobiol. B, Biol. 2016, 155, 78–85. https://doi.org/10.1016/j.jphotobiol.2015.12.014.
(327) Flowers, N.; Hartley, L.; Todkill, D.; Stranges, S.; Rees, K. Co-Enzyme Q10 Supplementation for the Primary Prevention of Cardiovascular Disease. Cochrane Database Syst Rev 2014, No. 12, CD010405. https://doi.org/10.1002/14651858.CD010405.pub2.
(328) Singh, U.; Devaraj, S.; Jialal, I. Coenzyme Q10 Supplementation and Heart Failure. Nutr. Rev. 2007, 65 (6 Pt 1), 286–293. https://doi.org/10.1301/nr.2007.jun.286-293.
(329) Gao, L.; Mao, Q.; Cao, J.; Wang, Y.; Zhou, X.; Fan, L. Effects of Coenzyme Q10 on Vascular Endothelial Function in Humans: A Meta-Analysis of Randomized Controlled Trials. Atherosclerosis 2012, 221 (2), 311–316. https://doi.org/10.1016/j.atherosclerosis.2011.10.027.
(330) DiNicolantonio, J. J.; Bhutani, J.; McCarty, M. F.; O’Keefe, J. H. Coenzyme Q10 for the Treatment of Heart Failure: A Review of the Literature. Open Heart 2015, 2 (1), e000326. https://doi.org/10.1136/openhrt-2015-000326.
(331) Ayers, J.; Cook, J.; Koenig, R. A.; Sisson, E. M.; Dixon, D. L. Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: A Systematic Review. Curr Atheroscler Rep 2018, 20 (6), 29. https://doi.org/10.1007/s11883-018-0730-1.
(332) Mortensen, A. L.; Rosenfeldt, F.; Filipiak, K. J. Effect of Coenzyme Q10 in Europeans with Chronic Heart Failure: A Sub-Group Analysis of the Q-SYMBIO Randomized Double-Blind Trial. Cardiol J 2019, 26 (2), 147–156. https://doi.org/10.5603/CJ.a2019.0022.
(333) Fabre, L. F.; Banks, R. C.; Mcisaac, W. M.; Farrell, G. Effects of Ubiquinone and Related Substances on Secretion of Aldosterone and Cortisol. Am. J. Physiol. 1965, 208, 1275–1280. https://doi.org/10.1152/ajplegacy.1965.208.6.1275.
(334) Langsjoen, P.; Langsjoen, P.; Willis, R.; Folkers, K. Treatment of Essential Hypertension with Coenzyme Q10. Mol. Aspects Med. 1994, 15 Suppl, S265-272. https://doi.org/10.1016/0098-2997(94)90037-x.
(335) Digiesi, V.; Cantini, F.; Oradei, A.; Bisi, G.; Guarino, G. C.; Brocchi, A.; Bellandi, F.; Mancini, M.; Littarru, G. P. Coenzyme Q10 in Essential Hypertension. Mol. Aspects Med. 1994, 15 Suppl, s257-263. https://doi.org/10.1016/0098-2997(94)90036-1.
(336) Grunfeld, S.; Hamilton, C. A.; Mesaros, S.; McClain, S. W.; Dominiczak, A. F.; Bohr, D. F.; Malinski, T. Role of Superoxide in the Depressed Nitric Oxide Production by the Endothelium of Genetically Hypertensive Rats. Hypertension 1995, 26 (6 Pt 1), 854–857. https://doi.org/10.1161/01.hyp.26.6.854.
(337) Burke, B. E.; Neuenschwander, R.; Olson, R. D. Randomized, Double-Blind, Placebo-Controlled Trial of Coenzyme Q10 in Isolated Systolic Hypertension. South. Med. J. 2001, 94 (11), 1112–1117. https://doi.org/10.1097/00007611-200111000-00015.
(338) Rosenfeldt, F. L.; Haas, S. J.; Krum, H.; Hadj, A.; Ng, K.; Leong, J.-Y.; Watts, G. F. Coenzyme Q10 in the Treatment of Hypertension: A Meta-Analysis of the Clinical Trials. J Hum Hypertens 2007, 21 (4), 297–306. https://doi.org/10.1038/sj.jhh.1002138.
(339) Ho, M. J.; Li, E. C. K.; Wright, J. M. Blood Pressure Lowering Efficacy of Coenzyme Q10 for Primary Hypertension. Cochrane Database Syst Rev 2016, 3, CD007435. https://doi.org/10.1002/14651858.CD007435.pub3.
(340) Shao, L.; Ma, A.; Figtree, G.; Zhang, P. Combination Therapy With Coenzyme Q10 and Trimetazidine in Patients With Acute Viral Myocarditis. J. Cardiovasc. Pharmacol. 2016, 68 (2), 150–154. https://doi.org/10.1097/FJC.0000000000000396.
(341) Tiano, L.; Belardinelli, R.; Carnevali, P.; Principi, F.; Seddaiu, G.; Littarru, G. P. Effect of Coenzyme Q10 Administration on Endothelial Function and Extracellular Superoxide Dismutase in Patients with Ischaemic Heart Disease: A Double-Blind, Randomized Controlled Study. Eur. Heart J. 2007, 28 (18), 2249–2255. https://doi.org/10.1093/eurheartj/ehm267.
(342) Dai, Y.-L.; Luk, T.-H.; Yiu, K.-H.; Wang, M.; Yip, P. M. C.; Lee, S. W. L.; Li, S.-W.; Tam, S.; Fong, B.; Lau, C.-P.; Siu, C.-W.; Tse, H.-F. Reversal of Mitochondrial Dysfunction by Coenzyme Q10 Supplement Improves Endothelial Function in Patients with Ischaemic Left Ventricular Systolic Dysfunction: A Randomized Controlled Trial. Atherosclerosis 2011, 216 (2), 395–401. https://doi.org/10.1016/j.atherosclerosis.2011.02.013.
(343) Lee, B.-J.; Huang, Y.-C.; Chen, S.-J.; Lin, P.-T. Effects of Coenzyme Q10 Supplementation on Inflammatory Markers (High-Sensitivity C-Reactive Protein, Interleukin-6, and Homocysteine) in Patients with Coronary Artery Disease. Nutrition 2012, 28 (7–8), 767–772. https://doi.org/10.1016/j.nut.2011.11.008.
(344) Lee, B.-J.; Tseng, Y.-F.; Yen, C.-H.; Lin, P.-T. Effects of Coenzyme Q10 Supplementation (300 Mg/Day) on Antioxidation and Anti-Inflammation in Coronary Artery Disease Patients during Statins Therapy: A Randomized, Placebo-Controlled Trial. Nutr J 2013, 12 (1), 142. https://doi.org/10.1186/1475-2891-12-142.
(345) Büyükkaya, E.; Evliyaoğlu, O.; Islamoğlu, Y.; Cil, H.; Karakaş, M. F.; Akçay, A. B.; Bilen, P.; Kurt, M.; Şen, N.; Ertas, F.; Mete, N. The Relationship between Coenzyme Q10 and Severity of Coronary Artery Disease. Med Glas (Zenica) 2013, 10 (2), 229–233.
(346) Folkers, K.; Langsjoen, P.; Willis, R.; Richardson, P.; Xia, L. J.; Ye, C. Q.; Tamagawa, H. Lovastatin Decreases Coenzyme Q Levels in Humans. Proc Natl Acad Sci U S A 1990, 87 (22), 8931–8934.
(347) Ghirlanda, G.; Oradei, A.; Manto, A.; Lippa, S.; Uccioli, L.; Caputo, S.; Greco, A. V.; Littarru, G. P. Evidence of Plasma CoQ10-Lowering Effect by HMG-CoA Reductase Inhibitors: A Double-Blind, Placebo-Controlled Study. J Clin Pharmacol 1993, 33 (3), 226–229. https://doi.org/10.1002/j.1552-4604.1993.tb03948.x.
(348) Langsjoen, P. H.; Langsjoen, A. M. The Clinical Use of HMG CoA-Reductase Inhibitors and the Associated Depletion of Coenzyme Q10. A Review of Animal and Human Publications. Biofactors 2003, 18 (1–4), 101–111. https://doi.org/10.1002/biof.5520180212.
(349) Silver, M. A.; Langsjoen, P. H.; Szabo, S.; Patil, H.; Zelinger, A. Statin Cardiomyopathy? A Potential Role for Co-Enzyme Q10 Therapy for Statin-Induced Changes in Diastolic LV Performance: Description of a Clinical Protocol. Biofactors 2003, 18 (1–4), 125–127. https://doi.org/10.1002/biof.5520180214.
(350) Silver, M. A.; Langsjoen, P. H.; Szabo, S.; Patil, H.; Zelinger, A. Effect of Atorvastatin on Left Ventricular Diastolic Function and Ability of Coenzyme Q10 to Reverse That Dysfunction. Am. J. Cardiol. 2004, 94 (10), 1306–1310. https://doi.org/10.1016/j.amjcard.2004.07.121.
(351) Hargreaves, I. P.; Duncan, A. J.; Heales, S. J. R.; Land, J. M. The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q10: Possible Biochemical/Clinical Implications. Drug Saf 2005, 28 (8), 659–676. https://doi.org/10.2165/00002018-200528080-00002.
(352) Stocker, R.; Pollicino, C.; Gay, C. A.; Nestel, P.; Colquhoun, D.; Whiting, M.; Tonkin, A.; Sullivan, D.; Simes, J. Neither Plasma Coenzyme Q10 Concentration, nor Its Decline during Pravastatin Therapy, Is Linked to Recurrent Cardiovascular Disease Events: A Prospective Case-Control Study from the LIPID Study. Atherosclerosis 2006, 187 (1), 198–204. https://doi.org/10.1016/j.atherosclerosis.2005.09.004.
(353) Mortensen, S. A.; Rosenfeldt, F.; Kumar, A.; Dolliner, P.; Filipiak, K. J.; Pella, D.; Alehagen, U.; Steurer, G.; Littarru, G. P.; Q-SYMBIO Study Investigators. The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure: Results from Q-SYMBIO: A Randomized Double-Blind Trial. JACC Heart Fail 2014, 2 (6), 641–649. https://doi.org/10.1016/j.jchf.2014.06.008.
(354) Engelsen, J.; Nielsen, J. D.; Winther, K. Effect of Coenzyme Q10 and Ginkgo Biloba on Warfarin Dosage in Stable, Long-Term Warfarin Treated Outpatients. A Randomised, Double Blind, Placebo-Crossover Trial. Thromb. Haemost. 2002, 87 (6), 1075–1076.
(355) Engelsen, J.; Nielsen, J. D.; Hansen, K. F. W. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr. Laeg. 2003, 165 (18), 1868–1871.
(356) El-ghoroury, E. A.; Raslan, H. M.; Badawy, E. A.; El-Saaid, G. S.; Agybi, M. H.; Siam, I.; Salem, S. I. Malondialdehyde and Coenzyme Q10 in Platelets and Serum in Type 2 Diabetes Mellitus: Correlation with Glycemic Control. Blood Coagul. Fibrinolysis 2009, 20 (4), 248–251. https://doi.org/10.1097/mbc.0b013e3283254549.
(357) Sourris, K. C.; Harcourt, B. E.; Tang, P. H.; Morley, A. L.; Huynh, K.; Penfold, S. A.; Coughlan, M. T.; Cooper, M. E.; Nguyen, T.-V.; Ritchie, R. H.; Forbes, J. M. Ubiquinone (Coenzyme Q10) Prevents Renal Mitochondrial Dysfunction in an Experimental Model of Type 2 Diabetes. Free Radic. Biol. Med. 2012, 52 (3), 716–723. https://doi.org/10.1016/j.freeradbiomed.2011.11.017.
(358) Ates, O.; Bilen, H.; Keles, S.; Alp, H. H.; Keleş, M. S.; Yıldırım, K.; Ondaş, O.; Pınar, L. C.; Civelekler, M.; Baykal, O. Plasma Coenzyme Q10 Levels in Type 2 Diabetic Patients with Retinopathy. Int J Ophthalmol 2013, 6 (5), 675–679. https://doi.org/10.3980/j.issn.2222-3959.2013.05.24.
(359) Zozina, V. I.; Covantev, S.; Goroshko, O. A.; Krasnykh, L. M.; Kukes, V. G. Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem. Curr Cardiol Rev 2018, 14 (3), 164–174. https://doi.org/10.2174/1573403X14666180416115428.
(360) Parkinson Study Group QE3 Investigators; Beal, M. F.; Oakes, D.; Shoulson, I.; Henchcliffe, C.; Galpern, W. R.; Haas, R.; Juncos, J. L.; Nutt, J. G.; Voss, T. S.; Ravina, B.; Shults, C. M.; Helles, K.; Snively, V.; Lew, M. F.; Griebner, B.; Watts, A.; Gao, S.; Pourcher, E.; Bond, L.; Kompoliti, K.; Agarwal, P.; Sia, C.; Jog, M.; Cole, L.; Sultana, M.; Kurlan, R.; Richard, I.; Deeley, C.; Waters, C. H.; Figueroa, A.; Arkun, A.; Brodsky, M.; Ondo, W. G.; Hunter, C. B.; Jimenez-Shahed, J.; Palao, A.; Miyasaki, J. M.; So, J.; Tetrud, J.; Reys, L.; Smith, K.; Singer, C.; Blenke, A.; Russell, D. S.; Cotto, C.; Friedman, J. H.; Lannon, M.; Zhang, L.; Drasby, E.; Kumar, R.; Subramanian, T.; Ford, D. S.; Grimes, D. A.; Cote, D.; Conway, J.; Siderowf, A. D.; Evatt, M. L.; Sommerfeld, B.; Lieberman, A. N.; Okun, M. S.; Rodriguez, R. L.; Merritt, S.; Swartz, C. L.; Martin, W. R. W.; King, P.; Stover, N.; Guthrie, S.; Watts, R. L.; Ahmed, A.; Fernandez, H. H.; Winters, A.; Mari, Z.; Dawson, T. M.; Dunlop, B.; Feigin, A. S.; Shannon, B.; Nirenberg, M. J.; Ogg, M.; Ellias, S. A.; Thomas, C.-A.; Frei, K.; Bodis-Wollner, I.; Glazman, S.; Mayer, T.; Hauser, R. A.; Pahwa, R.; Langhammer, A.; Ranawaya, R.; Derwent, L.; Sethi, K. D.; Farrow, B.; Prakash, R.; Litvan, I.; Robinson, A.; Sahay, A.; Gartner, M.; Hinson, V. K.; Markind, S.; Pelikan, M.; Perlmutter, J. S.; Hartlein, J.; Molho, E.; Evans, S.; Adler, C. H.; Duffy, A.; Lind, M.; Elmer, L.; Davis, K.; Spears, J.; Wilson, S.; Leehey, M. A.; Hermanowicz, N.; Niswonger, S.; Shill, H. A.; Obradov, S.; Rajput, A.; Cowper, M.; Lessig, S.; Song, D.; Fontaine, D.; Zadikoff, C.; Williams, K.; Blindauer, K. A.; Bergholte, J.; Propsom, C. S.; Stacy, M. A.; Field, J.; Mihaila, D.; Chilton, M.; Uc, E. Y.; Sieren, J.; Simon, D. K.; Kraics, L.; Silver, A.; Boyd, J. T.; Hamill, R. W.; Ingvoldstad, C.; Young, J.; Thomas, K.; Kostyk, S. K.; Wojcieszek, J.; Pfeiffer, R. F.; Panisset, M.; Beland, M.; Reich, S. G.; Cines, M.; Zappala, N.; Rivest, J.; Zweig, R.; Lumina, L. P.; Hilliard, C. L.; Grill, S.; Kellermann, M.; Tuite, P.; Rolandelli, S.; Kang, U. J.; Young, J.; Rao, J.; Cook, M. M.; Severt, L.; Boyar, K. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit. JAMA Neurol 2014, 71 (5), 543–552. https://doi.org/10.1001/jamaneurol.2014.131.
(361) Yoritaka, A.; Kawajiri, S.; Yamamoto, Y.; Nakahara, T.; Ando, M.; Hashimoto, K.; Nagase, M.; Saito, Y.; Hattori, N. Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Reduced Coenzyme Q10 for Parkinson’s Disease. Parkinsonism Relat. Disord. 2015, 21 (8), 911–916. https://doi.org/10.1016/j.parkreldis.2015.05.022.
(362) Negida, A.; Menshawy, A.; El Ashal, G.; Elfouly, Y.; Hani, Y.; Hegazy, Y.; El Ghonimy, S.; Fouda, S.; Rashad, Y. Coenzyme Q10 for Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis. CNS Neurol Disord Drug Targets 2016, 15 (1), 45–53. https://doi.org/10.2174/1871527314666150821103306.
(363) Galasko, D. R.; Peskind, E.; Clark, C. M.; Quinn, J. F.; Ringman, J. M.; Jicha, G. A.; Cotman, C.; Cottrell, B.; Montine, T. J.; Thomas, R. G.; Aisen, P.; Alzheimer’s Disease Cooperative Study. Antioxidants for Alzheimer Disease: A Randomized Clinical Trial with Cerebrospinal Fluid Biomarker Measures. Arch. Neurol. 2012, 69 (7), 836–841. https://doi.org/10.1001/archneurol.2012.85.
(364) McGarry, A.; McDermott, M.; Kieburtz, K.; de Blieck, E. A.; Beal, F.; Marder, K.; Ross, C.; Shoulson, I.; Gilbert, P.; Mallonee, W. M.; Guttman, M.; Wojcieszek, J.; Kumar, R.; LeDoux, M. S.; Jenkins, M.; Rosas, H. D.; Nance, M.; Biglan, K.; Como, P.; Dubinsky, R. M.; Shannon, K. M.; O’Suilleabhain, P.; Chou, K.; Walker, F.; Martin, W.; Wheelock, V. L.; McCusker, E.; Jankovic, J.; Singer, C.; Sanchez-Ramos, J.; Scott, B.; Suchowersky, O.; Factor, S. A.; Higgins, D. S.; Molho, E.; Revilla, F.; Caviness, J. N.; Friedman, J. H.; Perlmutter, J. S.; Feigin, A.; Anderson, K.; Rodriguez, R.; McFarland, N. R.; Margolis, R. L.; Farbman, E. S.; Raymond, L. A.; Suski, V.; Kostyk, S.; Colcher, A.; Seeberger, L.; Epping, E.; Esmail, S.; Diaz, N.; Fung, W. L. A.; Diamond, A.; Frank, S.; Hanna, P.; Hermanowicz, N.; Dure, L. S.; Cudkowicz, M.; Huntington Study Group 2CARE Investigators and Coordinators. A Randomized, Double-Blind, Placebo-Controlled Trial of Coenzyme Q10 in Huntington Disease. Neurology 2017, 88 (2), 152–159. https://doi.org/10.1212/WNL.0000000000003478.
(365) Cooper, J. M.; Schapira, A. H. V. Friedreich’s Ataxia: Disease Mechanisms, Antioxidant and Coenzyme Q10 Therapy. Biofactors 2003, 18 (1–4), 163–171. https://doi.org/10.1002/biof.5520180219.
(366) Hart, P. E.; Lodi, R.; Rajagopalan, B.; Bradley, J. L.; Crilley, J. G.; Turner, C.; Blamire, A. M.; Manners, D.; Styles, P.; Schapira, A. H. V.; Cooper, J. M. Antioxidant Treatment of Patients with Friedreich Ataxia: Four-Year Follow-Up. Arch. Neurol. 2005, 62 (4), 621–626. https://doi.org/10.1001/archneur.62.4.621.
(367) Cooper, J. M.; Korlipara, L. V. P.; Hart, P. E.; Bradley, J. L.; Schapira, A. H. V. Coenzyme Q10 and Vitamin E Deficiency in Friedreich’s Ataxia: Predictor of Efficacy of Vitamin E and Coenzyme Q10 Therapy. Eur. J. Neurol. 2008, 15 (12), 1371–1379. https://doi.org/10.1111/j.1468-1331.2008.02318.x.
(368) Sanoobar, M.; Eghtesadi, S.; Azimi, A.; Khalili, M.; Khodadadi, B.; Jazayeri, S.; Gohari, M. R.; Aryaeian, N. Coenzyme Q10 Supplementation Ameliorates Inflammatory Markers in Patients with Multiple Sclerosis: A Double Blind, Placebo, Controlled Randomized Clinical Trial. Nutr Neurosci 2015, 18 (4), 169–176. https://doi.org/10.1179/1476830513Y.0000000106.
(369) Sanoobar, M.; Dehghan, P.; Khalili, M.; Azimi, A.; Seifar, F. Coenzyme Q10 as a Treatment for Fatigue and Depression in Multiple Sclerosis Patients: A Double Blind Randomized Clinical Trial. Nutr Neurosci 2016, 19 (3), 138–143. https://doi.org/10.1179/1476830515Y.0000000002.
(370) Moccia, M.; Capacchione, A.; Lanzillo, R.; Carbone, F.; Micillo, T.; Matarese, G.; Palladino, R.; Brescia Morra, V. Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-Β1a and Coenzyme Q10. Brain Sci 2019, 9 (10). https://doi.org/10.3390/brainsci9100259.
(371) Moccia, M.; Capacchione, A.; Lanzillo, R.; Carbone, F.; Micillo, T.; Perna, F.; De Rosa, A.; Carotenuto, A.; Albero, R.; Matarese, G.; Palladino, R.; Brescia Morra, V. Coenzyme Q10 Supplementation Reduces Peripheral Oxidative Stress and Inflammation in Interferon-Β1a-Treated Multiple Sclerosis. Ther Adv Neurol Disord 2019, 12. https://doi.org/10.1177/1756286418819074.
(372) Cordero, M. D.; Alcocer-Gómez, E.; de Miguel, M.; Culic, O.; Carrión, A. M.; Alvarez-Suarez, J. M.; Bullón, P.; Battino, M.; Fernández-Rodríguez, A.; Sánchez-Alcazar, J. A. Can Coenzyme Q10 Improve Clinical and Molecular Parameters in Fibromyalgia? Antioxid. Redox Signal. 2013, 19 (12), 1356–1361. https://doi.org/10.1089/ars.2013.5260.
(373) Alcocer-Gómez, E.; Culic, O.; Navarro-Pando, J. M.; Sánchez-Alcázar, J. A.; Bullón, P. Effect of Coenzyme Q10 on Psychopathological Symptoms in Fibromyalgia Patients. CNS Neurosci Ther 2017, 23 (2), 188–189. https://doi.org/10.1111/cns.12668.
(374) Safarinejad, M. R. Safety and Efficacy of Coenzyme Q10 Supplementation in Early Chronic Peyronie’s Disease: A Double-Blind, Placebo-Controlled Randomized Study. Int. J. Impot. Res. 2010, 22 (5), 298–309. https://doi.org/10.1038/ijir.2010.20.
(375) Kuehhas, F. E.; Weibl, P.; Georgi, T.; Djakovic, N.; Herwig, R. Peyronie’s Disease: Nonsurgical Therapy Options. Rev Urol 2011, 13 (3), 139–146.
(376) Safarinejad, M. R.; Safarinejad, S.; Shafiei, N.; Safarinejad, S. Effects of the Reduced Form of Coenzyme Q10 (Ubiquinol) on Semen Parameters in Men with Idiopathic Infertility: A Double-Blind, Placebo Controlled, Randomized Study. J. Urol. 2012, 188 (2), 526–531. https://doi.org/10.1016/j.juro.2012.03.131.
(377) Lafuente, R.; González-Comadrán, M.; Solà, I.; López, G.; Brassesco, M.; Carreras, R.; Checa, M. A. Coenzyme Q10 and Male Infertility: A Meta-Analysis. J. Assist. Reprod. Genet. 2013, 30 (9), 1147–1156. https://doi.org/10.1007/s10815-013-0047-5.
(378) Arcaniolo, D.; Favilla, V.; Tiscione, D.; Pisano, F.; Bozzini, G.; Creta, M.; Gentile, G.; Menchini Fabris, F.; Pavan, N.; Veneziano, I. A.; Cai, T. Is There a Place for Nutritional Supplements in the Treatment of Idiopathic Male Infertility? Arch Ital Urol Androl 2014, 86 (3), 164–170. https://doi.org/10.4081/aiua.2014.3.164.
(379) Gvozdjáková, A.; Kucharská, J.; Dubravicky, J.; Mojto, V.; Singh, R. B. Coenzyme Q₁₀, α-Tocopherol, and Oxidative Stress Could Be Important Metabolic Biomarkers of Male Infertility. Dis. Markers 2015, 2015, 827941. https://doi.org/10.1155/2015/827941.
(380) Al-Rasheed, N. M.; Al-Rasheed, N. M.; Bassiouni, Y. A.; Hasan, I. H.; Al-Amin, M. A.; Al-Ajmi, H. N.; Mohamad, R. A. Vitamin D Attenuates Pro-Inflammatory TNF-α Cytokine Expression by Inhibiting NF-КB/P65 Signaling in Hypertrophied Rat Hearts. J. Physiol. Biochem. 2015, 71 (2), 289–299. https://doi.org/10.1007/s13105-015-0412-1.
(381) Silvagno, F.; Pescarmona, G. Spotlight on Vitamin D Receptor, Lipid Metabolism and Mitochondria: Some Preliminary Emerging Issues. Mol. Cell. Endocrinol. 2017, 450, 24–31. https://doi.org/10.1016/j.mce.2017.04.013.
(382) Ryan, Z. C.; Craig, T. A.; Folmes, C. D.; Wang, X.; Lanza, I. R.; Schaible, N. S.; Salisbury, J. L.; Nair, K. S.; Terzic, A.; Sieck, G. C.; Kumar, R. 1α,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells. J. Biol. Chem. 2016, 291 (3), 1514–1528. https://doi.org/10.1074/jbc.M115.684399.
(383) Dzik, K. P.; Kaczor, J. J. Mechanisms of Vitamin D on Skeletal Muscle Function: Oxidative Stress, Energy Metabolism and Anabolic State. Eur. J. Appl. Physiol. 2019, 119 (4), 825–839. https://doi.org/10.1007/s00421-019-04104-x.
(384) Dzik, K. P.; Skrobot, W.; Kaczor, K. B.; Flis, D. J.; Karnia, M. J.; Libionka, W.; Antosiewicz, J.; Kloc, W.; Kaczor, J. J. Vitamin D Deficiency Is Associated with Muscle Atrophy and Reduced Mitochondrial Function in Patients with Chronic Low Back Pain https://www.hindawi.com/journals/omcl/2019/6835341/ (accessed May 5, 2020). https://doi.org/10.1155/2019/6835341.
(385) Schnell, D. M.; Walton, R. G.; Vekaria, H. J.; Sullivan, P. G.; Bollinger, L. M.; Peterson, C. A.; Thomas, D. T. Vitamin D Produces a Perilipin 2-Dependent Increase in Mitochondrial Function in C2C12 Myotubes. J. Nutr. Biochem. 2019, 65, 83–92. https://doi.org/10.1016/j.jnutbio.2018.11.002.
(386) Consiglio, M.; Destefanis, M.; Morena, D.; Foglizzo, V.; Forneris, M.; Pescarmona, G.; Silvagno, F. The Vitamin D Receptor Inhibits the Respiratory Chain, Contributing to the Metabolic Switch That Is Essential for Cancer Cell Proliferation. PLOS ONE 2014, 9 (12), e115816. https://doi.org/10.1371/journal.pone.0115816.
(387) Consiglio, M.; Viano, M.; Casarin, S.; Castagnoli, C.; Pescarmona, G.; Silvagno, F. Mitochondrial and Lipogenic Effects of Vitamin D on Differentiating and Proliferating Human Keratinocytes. Experimental Dermatology 2015, 24 (10), 748–753. https://doi.org/10.1111/exd.12761.
(388) Al-Hendy, A.; Diamond, M. P.; Boyer, T. G.; Halder, S. K. Vitamin D3 Inhibits Wnt/β-Catenin and MTOR Signaling Pathways in Human Uterine Fibroid Cells. J. Clin. Endocrinol. Metab. 2016, 101 (4), 1542–1551. https://doi.org/10.1210/jc.2015-3555.
(389) Hoepner, R.; Bagnoud, M.; Pistor, M.; Salmen, A.; Briner, M.; Synn, H.; Schrewe, L.; Guse, K.; Ahmadi, F.; Demir, S.; Laverick, L.; Gresle, M.; Worley, P.; Reichardt, H. M.; Butzkueven, H.; Gold, R.; Metz, I.; Lühder, F.; Chan, A. Vitamin D Increases Glucocorticoid Efficacy via Inhibition of MTORC1 in Experimental Models of Multiple Sclerosis. Acta Neuropathol. 2019, 138 (3), 443–456. https://doi.org/10.1007/s00401-019-02018-8.
(390) Rauen, U.; Springer, A.; Weisheit, D.; Petrat, F.; Korth, H.-G.; de Groot, H.; Sustmann, R. Assessment of Chelatable Mitochondrial Iron by Using Mitochondrion-Selective Fluorescent Iron Indicators with Different Iron-Binding Affinities. Chembiochem 2007, 8 (3), 341–352. https://doi.org/10.1002/cbic.200600311.
(391) Paul, B. T.; Manz, D. H.; Torti, F. M.; Torti, S. V. Mitochondria and Iron: Current Questions. Expert Rev Hematol 2017, 10 (1), 65–79. https://doi.org/10.1080/17474086.2016.1268047.
(392) Favaro, E.; Ramachandran, A.; McCormick, R.; Gee, H.; Blancher, C.; Crosby, M.; Devlin, C.; Blick, C.; Buffa, F.; Li, J.-L.; Vojnovic, B.; Pires das Neves, R.; Glazer, P.; Iborra, F.; Ivan, M.; Ragoussis, J.; Harris, A. L. MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU. PLoS ONE 2010, 5 (4), e10345. https://doi.org/10.1371/journal.pone.0010345.
(393) Sullivan, L. B.; Chandel, N. S. Mitochondrial Reactive Oxygen Species and Cancer. Cancer Metab 2014, 2. https://doi.org/10.1186/2049-3002-2-17.
(394) Nie, G.; Sheftel, A. D.; Kim, S. F.; Ponka, P. Overexpression of Mitochondrial Ferritin Causes Cytosolic Iron Depletion and Changes Cellular Iron Homeostasis. Blood 2005, 105 (5), 2161–2167. https://doi.org/10.1182/blood-2004-07-2722.
(395) Jarvis, J. H.; Jacobs, A. Morphological Abnormalities in Lymphocyte Mitochondria Associated with Iron-Deficiency Anaemia. J. Clin. Pathol. 1974, 27 (12), 973–979. https://doi.org/10.1136/jcp.27.12.973.
(396) Masini, A.; Salvioli, G.; Cremonesi, P.; Botti, B.; Gallesi, D.; Ceccarelli, D. Dietary Iron Deficiency in the Rat. I. Abnormalities in Energy Metabolism of the Hepatic Tissue. Biochim. Biophys. Acta 1994, 1188 (1–2), 46–52. https://doi.org/10.1016/0005-2728(94)90020-5.
(397) Bacon, B. R.; O’Neill, R.; Britton, R. S. Hepatic Mitochondrial Energy Production in Rats with Chronic Iron Overload. Gastroenterology 1993, 105 (4), 1134–1140. https://doi.org/10.1016/0016-5085(93)90959-g.
(398) Gao, X.; Campian, J. L.; Qian, M.; Sun, X.-F.; Eaton, J. W. Mitochondrial DNA Damage in Iron Overload. J. Biol. Chem. 2009, 284 (8), 4767–4775. https://doi.org/10.1074/jbc.M806235200.
(399) Blanchette, N. L.; Manz, D. H.; Torti, F. M.; Torti, S. V. Modulation of Hepcidin to Treat Iron Deregulation: Potential Clinical Applications. Expert Rev Hematol 2016, 9 (2), 169–186. https://doi.org/10.1586/17474086.2016.1124757.
(400) Barbiroli, B.; Medori, R.; Tritschler, H. J.; Klopstock, T.; Seibel, P.; Reichmann, H.; Iotti, S.; Lodi, R.; Zaniol, P. Lipoic (Thioctic) Acid Increases Brain Energy Availability and Skeletal Muscle Performance as Shown by in Vivo 31P-MRS in a Patient with Mitochondrial Cytopathy. J. Neurol. 1995, 242 (7), 472–477. https://doi.org/10.1007/BF00873552.
(401) Mayr, J. A.; Zimmermann, F. A.; Fauth, C.; Bergheim, C.; Meierhofer, D.; Radmayr, D.; Zschocke, J.; Koch, J.; Sperl, W. Lipoic Acid Synthetase Deficiency Causes Neonatal-Onset Epilepsy, Defective Mitochondrial Energy Metabolism, and Glycine Elevation. Am. J. Hum. Genet. 2011, 89 (6), 792–797. https://doi.org/10.1016/j.ajhg.2011.11.011.
(402) Khanna, S.; Roy, S.; Packer, L.; Sen, C. K. Cytokine-Induced Glucose Uptake in Skeletal Muscle: Redox Regulation and the Role of Alpha-Lipoic Acid. Am. J. Physiol. 1999, 276 (5), R1327-1333. https://doi.org/10.1152/ajpregu.1999.276.5.R1327.
(403) Konrad, D.; Somwar, R.; Sweeney, G.; Yaworsky, K.; Hayashi, M.; Ramlal, T.; Klip, A. The Antihyperglycemic Drug Alpha-Lipoic Acid Stimulates Glucose Uptake via Both GLUT4 Translocation and GLUT4 Activation: Potential Role of P38 Mitogen-Activated Protein Kinase in GLUT4 Activation. Diabetes 2001, 50 (6), 1464–1471. https://doi.org/10.2337/diabetes.50.6.1464.
(404) Moini, H.; Tirosh, O.; Park, Y. C.; Cho, K.-J.; Packer, L. R-Alpha-Lipoic Acid Action on Cell Redox Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes. Arch. Biochem. Biophys. 2002, 397 (2), 384–391. https://doi.org/10.1006/abbi.2001.2680.
(405) Lee, W. J.; Song, K.-H.; Koh, E. H.; Won, J. C.; Kim, H. S.; Park, H.-S.; Kim, M.-S.; Kim, S.-W.; Lee, K.-U.; Park, J.-Y. Alpha-Lipoic Acid Increases Insulin Sensitivity by Activating AMPK in Skeletal Muscle. Biochem. Biophys. Res. Commun. 2005, 332 (3), 885–891. https://doi.org/10.1016/j.bbrc.2005.05.035.
(406) Ziegler, D. Thioctic Acid for Patients with Symptomatic Diabetic Polyneuropathy: A Critical Review. Treat Endocrinol 2004, 3 (3), 173–189. https://doi.org/10.2165/00024677-200403030-00005.
(407) Rochette, L.; Ghibu, S.; Muresan, A.; Vergely, C. Alpha-Lipoic Acid: Molecular Mechanisms and Therapeutic Potential in Diabetes. Can. J. Physiol. Pharmacol. 2015, 93 (12), 1021–1027. https://doi.org/10.1139/cjpp-2014-0353.
(408) Ziegler, D.; Low, P. A.; Freeman, R.; Tritschler, H.; Vinik, A. I. Predictors of Improvement and Progression of Diabetic Polyneuropathy Following Treatment with α-Lipoic Acid for 4 Years in the NATHAN 1 Trial. J. Diabetes Complicat. 2016, 30 (2), 350–356. https://doi.org/10.1016/j.jdiacomp.2015.10.018.
(409) Grassi, D.; Desideri, G.; Croce, G.; Tiberti, S.; Aggio, A.; Ferri, C. Flavonoids, Vascular Function and Cardiovascular Protection. Curr. Pharm. Des. 2009, 15 (10), 1072–1084. https://doi.org/10.2174/138161209787846982.
(410) Haritoglou, C.; Gerss, J.; Hammes, H. P.; Kampik, A.; Ulbig, M. W.; RETIPON Study Group. Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema. Ophthalmologica 2011, 226 (3), 127–137. https://doi.org/10.1159/000329470.
(411) Koufaki, M. Therapeutic Applications of Lipoic Acid: A Patent Review (2011 – 2014). Expert Opin Ther Pat 2014, 24 (9), 993–1005. https://doi.org/10.1517/13543776.2014.937425.
(412) Ghibu, S.; Craciun, C. E.; Rusu, R.; Morgovan, C.; Mogosan, C.; Rochette, L.; Gal, A. F.; Dronca, M. Impact of Alpha-Lipoic Acid Chronic Discontinuous Treatment in Cardiometabolic Disorders and Oxidative Stress Induced by Fructose Intake in Rats. Antioxidants (Basel) 2019, 8 (12). https://doi.org/10.3390/antiox8120636.
(413) Seifar, F.; Khalili, M.; Khaledyan, H.; Amiri Moghadam, S.; Izadi, A.; Azimi, A.; Shakouri, S. K. α-Lipoic Acid, Functional Fatty Acid, as a Novel Therapeutic Alternative for Central Nervous System Diseases: A Review. Nutr Neurosci 2019, 22 (5), 306–316. https://doi.org/10.1080/1028415X.2017.1386755.
(414) dos Santos, S. M.; Romeiro, C. F. R.; Rodrigues, C. A.; Cerqueira, A. R. L.; Monteiro, M. C. Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease? Oxid Med Cell Longev 2019, 2019. https://doi.org/10.1155/2019/8409329.
(415) Loy, B. D.; Fling, B. W.; Horak, F. B.; Bourdette, D. N.; Spain, R. I. Effects of Lipoic Acid on Walking Performance, Gait, and Balance in Secondary Progressive Multiple Sclerosis. Complement Ther Med 2018, 41, 169–174. https://doi.org/10.1016/j.ctim.2018.09.006.
(416) Shinto, L.; Quinn, J.; Montine, T.; Dodge, H. H.; Woodward, W.; Baldauf-Wagner, S.; Waichunas, D.; Bumgarner, L.; Bourdette, D.; Silbert, L.; Kaye, J. A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer’s Disease. J. Alzheimers Dis. 2014, 38 (1), 111–120. https://doi.org/10.3233/JAD-130722.
(417) Zhang, H.; Jia, H.; Liu, J.; Ao, N.; Yan, B.; Shen, W.; Wang, X.; Li, X.; Luo, C.; Liu, J. Combined R-Alpha-Lipoic Acid and Acetyl-L-Carnitine Exerts Efficient Preventative Effects in a Cellular Model of Parkinson’s Disease. J. Cell. Mol. Med. 2010, 14 (1–2), 215–225. https://doi.org/10.1111/j.1582-4934.2008.00390.x.
(418) De Araújo, D. P.; Lobato, R. D. F. G.; Cavalcanti, J. R. L. D. P.; Sampaio, L. R. L.; Araújo, P. V. P.; Silva, M. C. C.; Neves, K. R. T.; Fonteles, M. M. D. F.; Sousa, F. C. F. D.; Vasconcelos, S. M. M. The Contributions of Antioxidant Activity of Lipoic Acid in Reducing Neurogenerative Progression of Parkinson’s Disease: A Review. Int. J. Neurosci. 2011, 121 (2), 51–57. https://doi.org/10.3109/00207454.2010.535934.
(419) Porcaro, G.; Brillo, E.; Giardina, I.; Di Iorio, R. Alpha Lipoic Acid (ALA) Effects on Subchorionic Hematoma: Preliminary Clinical Results. Eur Rev Med Pharmacol Sci 2015, 19 (18), 3426–3432.
(420) Costantino, M.; Guaraldi, C.; Costantino, D. Resolution of Subchorionic Hematoma and Symptoms of Threatened Miscarriage Using Vaginal Alpha Lipoic Acid or Progesterone: Clinical Evidences. Eur Rev Med Pharmacol Sci 2016, 20 (8), 1656–1663.
(421) Grandi, G.; Pignatti, L.; Ferrari, F.; Dante, G.; Neri, I.; Facchinetti, F. Vaginal Alpha-Lipoic Acid Shows an Anti-Inflammatory Effect on the Cervix, Preventing Its Shortening after Primary Tocolysis. A Pilot, Randomized, Placebo-Controlled Study. J. Matern. Fetal. Neonatal. Med. 2017, 30 (18), 2243–2249. https://doi.org/10.1080/14767058.2016.1245282.
(422) Eser Faki, H.; Tras, B.; Uney, K. Alpha Lipoic Acid and Vitamin E Improve Atorvastatin-Induced Mitochondrial Dysfunctions in Rats. Mitochondrion 2020, 52, 83–88. https://doi.org/10.1016/j.mito.2020.02.011.
(423) El Midaoui, A.; de Champlain, J. Prevention of Hypertension, Insulin Resistance, and Oxidative Stress by Alpha-Lipoic Acid. Hypertension 2002, 39 (2), 303–307. https://doi.org/10.1161/hy0202.104345.
(424) Vasdev, S.; Gill, V.; Parai, S.; Gadag, V. Dietary Lipoic Acid Supplementation Attenuates Hypertension in Dahl Salt Sensitive Rats. Mol. Cell. Biochem. 2005, 275 (1–2), 135–141. https://doi.org/10.1007/s11010-005-1095-7.
(425) Zanelli, S. A.; Solenski, N. J.; Rosenthal, R. E.; Fiskum, G. Mechanisms of Ischemic Neuroprotection by Acetyl-L-Carnitine. Ann N Y Acad Sci 2005, 1053, 153–161. https://doi.org/10.1196/annals.1344.013.
(426) Traina, G. The Neurobiology of Acetyl-L-Carnitine. Front Biosci (Landmark Ed) 2016, 21, 1314–1329.
(427) Ferreira, G. C.; McKenna, M. C. L-Carnitine and Acetyl-L-Carnitine Roles and Neuroprotection in Developing Brain. Neurochem. Res. 2017, 42 (6), 1661–1675. https://doi.org/10.1007/s11064-017-2288-7.
(428) Maldonado, C.; Vázquez, M.; Fagiolino, P. Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders. Curr. Pharm. Des. 2020. https://doi.org/10.2174/1381612826666200212114038.
(429) Tomassini, V.; Pozzilli, C.; Onesti, E.; Pasqualetti, P.; Marinelli, F.; Pisani, A.; Fieschi, C. Comparison of the Effects of Acetyl L-Carnitine and Amantadine for the Treatment of Fatigue in Multiple Sclerosis: Results of a Pilot, Randomised, Double-Blind, Crossover Trial. J. Neurol. Sci. 2004, 218 (1–2), 103–108. https://doi.org/10.1016/j.jns.2003.11.005.
(430) Ledinek, A. H.; Sajko, M. C.; Rot, U. Evaluating the Effects of Amantadin, Modafinil and Acetyl-L-Carnitine on Fatigue in Multiple Sclerosis–Result of a Pilot Randomized, Blind Study. Clin Neurol Neurosurg 2013, 115 Suppl 1, S86-89. https://doi.org/10.1016/j.clineuro.2013.09.029.
(431) Evans, E.; Piccio, L.; Cross, A. H. Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review. JAMA Neurol 2018, 75 (8), 1013–1021. https://doi.org/10.1001/jamaneurol.2018.0611.
(432) Zhang, H.; Jia, H.; Liu, J.; Ao, N.; Yan, B.; Shen, W.; Wang, X.; Li, X.; Luo, C.; Liu, J. Combined R-α–Lipoic Acid and Acetyl-L-Carnitine Exerts Efficient Preventative Effects in a Cellular Model of Parkinson’s Disease. J Cell Mol Med 2010, 14 (1–2), 215–225. https://doi.org/10.1111/j.1582-4934.2008.00390.x.
(433) Zaitone, S. A.; Abo-Elmatty, D. M.; Shaalan, A. A. Acetyl-L-Carnitine and α-Lipoic Acid Affect Rotenone-Induced Damage in Nigral Dopaminergic Neurons of Rat Brain, Implication for Parkinson’s Disease Therapy. Pharmacol. Biochem. Behav. 2012, 100 (3), 347–360. https://doi.org/10.1016/j.pbb.2011.09.002.
(434) Mehrotra, A.; Sandhir, R. Mitochondrial Cofactors in Experimental Huntington’s Disease: Behavioral, Biochemical and Histological Evaluation. Behav. Brain Res. 2014, 261, 345–355. https://doi.org/10.1016/j.bbr.2013.12.035.
(435) Saiki, S.; Hatano, T.; Fujimaki, M.; Ishikawa, K.-I.; Mori, A.; Oji, Y.; Okuzumi, A.; Fukuhara, T.; Koinuma, T.; Imamichi, Y.; Nagumo, M.; Furuya, N.; Nojiri, S.; Amo, T.; Yamashiro, K.; Hattori, N. Decreased Long-Chain Acylcarnitines from Insufficient β-Oxidation as Potential Early Diagnostic Markers for Parkinson’s Disease. Sci Rep 2017, 7 (1), 7328. https://doi.org/10.1038/s41598-017-06767-y.
(436) Afshin-Majd, S.; Bashiri, K.; Kiasalari, Z.; Baluchnejadmojarad, T.; Sedaghat, R.; Roghani, M. Acetyl-l-Carnitine Protects Dopaminergic Nigrostriatal Pathway in 6-Hydroxydopamine-Induced Model of Parkinson’s Disease in the Rat. Biomed. Pharmacother. 2017, 89, 1–9. https://doi.org/10.1016/j.biopha.2017.02.007.
(437) Burks, S.; Raymick, J.; Robinson, B.; Hanig, J.; Sarkar, S. Neuroprotective Effects of Acetyl-l-Carnitine (ALC) in a Chronic MPTP-Induced Parkinson’s Disease Mouse Model: Endothelial and Microglial Effects. Neurosci. Lett. 2019, 703, 86–95. https://doi.org/10.1016/j.neulet.2019.03.015.
(438) Spagnoli, A.; Lucca, U.; Menasce, G.; Bandera, L.; Cizza, G.; Forloni, G.; Tettamanti, M.; Frattura, L.; Tiraboschi, P.; Comelli, M. Long-Term Acetyl-L-Carnitine Treatment in Alzheimer’s Disease. Neurology 1991, 41 (11), 1726–1732. https://doi.org/10.1212/wnl.41.11.1726.
(439) Cristofano, A.; Sapere, N.; La Marca, G.; Angiolillo, A.; Vitale, M.; Corbi, G.; Scapagnini, G.; Intrieri, M.; Russo, C.; Corso, G.; Di Costanzo, A. Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer’s Dementia. PLoS ONE 2016, 11 (5), e0155694. https://doi.org/10.1371/journal.pone.0155694.
(440) Bachmann, H. U.; Hoffmann, A. Interaction of Food Supplement L-Carnitine with Oral Anticoagulant Acenocoumarol. Swiss Med Wkly 2004, 134 (25–26), 385. https://doi.org/2004/25/smw-10631.
(441) Drugs.com. Coumadin and L-Carnitine Drug Interactions https://www.drugs.com/drug-interactions/coumadin-with-l-carnitine-2311-1529-1454-13156.html (accessed May 7, 2020).
(442) Koeth, R. A.; Wang, Z.; Levison, B. S.; Buffa, J. A.; Org, E.; Sheehy, B. T.; Britt, E. B.; Fu, X.; Wu, Y.; Li, L.; Smith, J. D.; DiDonato, J. A.; Chen, J.; Li, H.; Wu, G. D.; Lewis, J. D.; Warrier, M.; Brown, J. M.; Krauss, R. M.; Tang, W. H. W.; Bushman, F. D.; Lusis, A. J.; Hazen, S. L. Intestinal Microbiota Metabolism of L-Carnitine, a Nutrient in Red Meat, Promotes Atherosclerosis. Nature Medicine 2013, 19 (5), 576–585. https://doi.org/10.1038/nm.3145.
(443) Tarnopolsky, M.; Martin, J. Creatine Monohydrate Increases Strength in Patients with Neuromuscular Disease. Neurology 1999, 52 (4), 854–857. https://doi.org/10.1212/wnl.52.4.854.
(444) Louis, M.; Lebacq, J.; Poortmans, J. R.; Belpaire-Dethiou, M.-C.; Devogelaer, J.-P.; Van Hecke, P.; Goubel, F.; Francaux, M. Beneficial Effects of Creatine Supplementation in Dystrophic Patients. Muscle Nerve 2003, 27 (5), 604–610. https://doi.org/10.1002/mus.10355.
(445) Tarnopolsky, M. A. Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders. Subcell. Biochem. 2007, 46, 183–204. https://doi.org/10.1007/978-1-4020-6486-9_10.
(446) Pfeffer, G.; Majamaa, K.; Turnbull, D. M.; Thorburn, D.; Chinnery, P. F. Treatment for Mitochondrial Disorders. Cochrane Database Syst Rev 2012, No. 4, CD004426. https://doi.org/10.1002/14651858.CD004426.pub3.
(447) Berneburg, M.; Gremmel, T.; Kürten, V.; Schroeder, P.; Hertel, I.; von Mikecz, A.; Wild, S.; Chen, M.; Declercq, L.; Matsui, M.; Ruzicka, T.; Krutmann, J. Creatine Supplementation Normalizes Mutagenesis of Mitochondrial DNA as Well as Functional Consequences. J. Invest. Dermatol. 2005, 125 (2), 213–220. https://doi.org/10.1111/j.0022-202X.2005.23806.x.
(448) Guidi, C.; Potenza, L.; Sestili, P.; Martinelli, C.; Guescini, M.; Stocchi, L.; Zeppa, S.; Polidori, E.; Annibalini, G.; Stocchi, V. Differential Effect of Creatine on Oxidatively-Injured Mitochondrial and Nuclear DNA. Biochim. Biophys. Acta 2008, 1780 (1), 16–26. https://doi.org/10.1016/j.bbagen.2007.09.018.
(449) Sestili, P.; Barbieri, E.; Martinelli, C.; Battistelli, M.; Guescini, M.; Vallorani, L.; Casadei, L.; D’Emilio, A.; Falcieri, E.; Piccoli, G.; Agostini, D.; Annibalini, G.; Paolillo, M.; Gioacchini, A. M.; Stocchi, V. Creatine Supplementation Prevents the Inhibition of Myogenic Differentiation in Oxidatively Injured C2C12 Murine Myoblasts. Mol Nutr Food Res 2009, 53 (9), 1187–1204. https://doi.org/10.1002/mnfr.200800504.
(450) Barbieri, E.; Guescini, M.; Calcabrini, C.; Vallorani, L.; Diaz, A. R.; Fimognari, C.; Canonico, B.; Luchetti, F.; Papa, S.; Battistelli, M.; Falcieri, E.; Romanello, V.; Sandri, M.; Stocchi, V.; Ciacci, C.; Sestili, P. Creatine Prevents the Structural and Functional Damage to Mitochondria in Myogenic, Oxidatively Stressed C2C12 Cells and Restores Their Differentiation Capacity. Oxid Med Cell Longev 2016, 2016. https://doi.org/10.1155/2016/5152029.
(451) Adhihetty, P. J.; Beal, M. F. Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases. Neuromolecular Med 2008, 10 (4), 275–290. https://doi.org/10.1007/s12017-008-8053-y.
(452) Mo, J.-J.; Liu, L.-Y.; Peng, W.-B.; Rao, J.; Liu, Z.; Cui, L.-L. The Effectiveness of Creatine Treatment for Parkinson’s Disease: An Updated Meta-Analysis of Randomized Controlled Trials. BMC Neurol 2017, 17. https://doi.org/10.1186/s12883-017-0885-3.
(453) Stevens, M. J.; Li, F.; Drel, V. R.; Abatan, O. I.; Kim, H.; Burnett, D.; Larkin, D.; Obrosova, I. G. Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic Rats. J. Pharmacol. Exp. Ther. 2007, 320 (1), 458–464. https://doi.org/10.1124/jpet.106.109702.
(454) Negi, G.; Kumar, A.; Kaundal, R. K.; Gulati, A.; Sharma, S. S. Functional and Biochemical Evidence Indicating Beneficial Effect of Melatonin and Nicotinamide Alone and in Combination in Experimental Diabetic Neuropathy. Neuropharmacology 2010, 58 (3), 585–592. https://doi.org/10.1016/j.neuropharm.2009.11.018.
(455) Maiese, K.; Chong, Z. Z. Nicotinamide: Necessary Nutrient Emerges as a Novel Cytoprotectant for the Brain. Trends Pharmacol. Sci. 2003, 24 (5), 228–232. https://doi.org/10.1016/S0165-6147(03)00078-6.
(456) Fricker, R. A.; Green, E. L.; Jenkins, S. I.; Griffin, S. M. The Influence of Nicotinamide on Health and Disease in the Central Nervous System. Int J Tryptophan Res 2018, 11. https://doi.org/10.1177/1178646918776658.
(457) Kaneko, S.; Wang, J.; Kaneko, M.; Yiu, G.; Hurrell, J. M.; Chitnis, T.; Khoury, S. J.; He, Z. Protecting Axonal Degeneration by Increasing Nicotinamide Adenine Dinucleotide Levels in Experimental Autoimmune Encephalomyelitis Models. J. Neurosci. 2006, 26 (38), 9794–9804. https://doi.org/10.1523/JNEUROSCI.2116-06.2006.
(458) Morris, M. C.; Evans, D. A.; Bienias, J. L.; Scherr, P. A.; Tangney, C. C.; Hebert, L. E.; Bennett, D. A.; Wilson, R. S.; Aggarwal, N. Dietary Niacin and the Risk of Incident Alzheimer’s Disease and of Cognitive Decline. J. Neurol. Neurosurg. Psychiatry 2004, 75 (8), 1093–1099. https://doi.org/10.1136/jnnp.2003.025858.
(459) Green, K. N.; Steffan, J. S.; Martinez-Coria, H.; Sun, X.; Schreiber, S. S.; Thompson, L. M.; LaFerla, F. M. Nicotinamide Restores Cognition in Alzheimer’s Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau. J Neurosci 2008, 28 (45), 11500–11510. https://doi.org/10.1523/JNEUROSCI.3203-08.2008.
(460) Bayrakdar, E. T.; Armagan, G.; Uyanikgil, Y.; Kanit, L.; Koylu, E.; Yalcin, A. Ex Vivo Protective Effects of Nicotinamide and 3-Aminobenzamide on Rat Synaptosomes Treated with Aβ(1-42). Cell Biochem. Funct. 2014, 32 (7), 557–564. https://doi.org/10.1002/cbf.3049.
(461) Lee, E.-J.; Wu, T.-S.; Chang, G.-L.; Li, C.-Y.; Chen, T.-Y.; Lee, M.-Y.; Chen, H.-Y.; Maynard, K. I. Delayed Treatment with Nicotinamide Inhibits Brain Energy Depletion, Improves Cerebral Microperfusion, Reduces Brain Infarct Volume, but Does Not Alter Neurobehavioral Outcome Following Permanent Focal Cerebral Ischemia in Sprague Dawley Rats. Curr Neurovasc Res 2006, 3 (3), 203–213. https://doi.org/10.2174/156720206778018749.
(462) Maiese, K.; Chong, Z. Z.; Hou, J.; Shang, Y. C. The Vitamin Nicotinamide: Translating Nutrition into Clinical Care. Molecules 2009, 14 (9), 3446–3485. https://doi.org/10.3390/molecules14093446.
(463) Martens, C. R.; Denman, B. A.; Mazzo, M. R.; Armstrong, M. L.; Reisdorph, N.; McQueen, M. B.; Chonchol, M.; Seals, D. R. Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults. Nat Commun 2018, 9 (1), 1286. https://doi.org/10.1038/s41467-018-03421-7.
(464) Dollerup, O. L.; Christensen, B.; Svart, M.; Schmidt, M. S.; Sulek, K.; Ringgaard, S.; Stødkilde-Jørgensen, H.; Møller, N.; Brenner, C.; Treebak, J. T.; Jessen, N. A Randomized Placebo-Controlled Clinical Trial of Nicotinamide Riboside in Obese Men: Safety, Insulin-Sensitivity, and Lipid-Mobilizing Effects. Am. J. Clin. Nutr. 2018, 108 (2), 343–353. https://doi.org/10.1093/ajcn/nqy132.
(465) Elhassan, Y. S.; Kluckova, K.; Fletcher, R. S.; Schmidt, M. S.; Garten, A.; Doig, C. L.; Cartwright, D. M.; Oakey, L.; Burley, C. V.; Jenkinson, N.; Wilson, M.; Lucas, S. J. E.; Akerman, I.; Seabright, A.; Lai, Y.-C.; Tennant, D. A.; Nightingale, P.; Wallis, G. A.; Manolopoulos, K. N.; Brenner, C.; Philp, A.; Lavery, G. G. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-Inflammatory Signatures. Cell Rep 2019, 28 (7), 1717-1728.e6. https://doi.org/10.1016/j.celrep.2019.07.043.
(466) Dollerup, O. L.; Chubanava, S.; Agerholm, M.; Søndergård, S. D.; Altıntaş, A.; Møller, A. B.; Høyer, K. F.; Ringgaard, S.; Stødkilde-Jørgensen, H.; Lavery, G. G.; Barrès, R.; Larsen, S.; Prats, C.; Jessen, N.; Treebak, J. T. Nicotinamide Riboside Does Not Alter Mitochondrial Respiration, Content or Morphology in Skeletal Muscle from Obese and Insulin-Resistant Men. J. Physiol. (Lond.) 2020, 598 (4), 731–754. https://doi.org/10.1113/JP278752.
(467) Remie, C. M. E.; Roumans, K. H. M.; Moonen, M. P. B.; Connell, N. J.; Havekes, B.; Mevenkamp, J.; Lindeboom, L.; de Wit, V. H. W.; van de Weijer, T.; Aarts, S. A. B. M.; Lutgens, E.; Schomakers, B. V.; Elfrink, H. L.; Zapata-Pérez, R.; Houtkooper, R. H.; Auwerx, J.; Hoeks, J.; Schrauwen-Hinderling, V. B.; Phielix, E.; Schrauwen, P. Nicotinamide Riboside Supplementation Alters Body Composition and Skeletal Muscle Acetylcarnitine Concentrations in Healthy Obese Humans. Am. J. Clin. Nutr. 2020. https://doi.org/10.1093/ajcn/nqaa072.
(468) Dellinger, R. W.; Santos, S. R.; Morris, M.; Evans, M.; Alminana, D.; Guarente, L.; Marcotulli, E. Repeat Dose NRPT (Nicotinamide Riboside and Pterostilbene) Increases NAD + Levels in Humans Safely and Sustainably: A Randomized, Double-Blind, Placebo-Controlled Study. npj Aging and Mechanisms of Disease 2017, 3 (1), 1–9. https://doi.org/10.1038/s41514-017-0016-9.
(469) Chou, Y.-F.; Huang, R.-F. S. Mitochondrial DNA Deletions of Blood Lymphocytes as Genetic Markers of Low Folate-Related Mitochondrial Genotoxicity in Peripheral Tissues. Eur J Nutr 2009, 48 (7), 429–436. https://doi.org/10.1007/s00394-009-0031-0.
(470) Ormazabal, A.; Casado, M.; Molero-Luis, M.; Montoya, J.; Rahman, S.; Aylett, S.-B.; Hargreaves, I.; Heales, S.; Artuch, R. Can Folic Acid Have a Role in Mitochondrial Disorders? Drug Discov. Today 2015, 20 (11), 1349–1354. https://doi.org/10.1016/j.drudis.2015.07.002.
(471) Sullivan, E. M.; Pennington, E. R.; Green, W. D.; Beck, M. A.; Brown, D. A.; Shaikh, S. R. Mechanisms by Which Dietary Fatty Acids Regulate Mitochondrial Structure-Function in Health and Disease. Adv Nutr 2018, 9 (3), 247–262. https://doi.org/10.1093/advances/nmy007.
(472) Sullivan, E. M.; Pennington, E. R.; Sparagna, G. C.; Torres, M. J.; Neufer, P. D.; Harris, M.; Washington, J.; Anderson, E. J.; Zeczycki, T. N.; Brown, D. A.; Shaikh, S. R. Docosahexaenoic Acid Lowers Cardiac Mitochondrial Enzyme Activity by Replacing Linoleic Acid in the Phospholipidome. J. Biol. Chem. 2018, 293 (2), 466–483. https://doi.org/10.1074/jbc.M117.812834.
(473) Herbst, E. a. F.; Paglialunga, S.; Gerling, C.; Whitfield, J.; Mukai, K.; Chabowski, A.; Heigenhauser, G. J. F.; Spriet, L. L.; Holloway, G. P. Omega-3 Supplementation Alters Mitochondrial Membrane Composition and Respiration Kinetics in Human Skeletal Muscle. J. Physiol. (Lond.) 2014, 592 (6), 1341–1352. https://doi.org/10.1113/jphysiol.2013.267336.
(474) Afshordel, S.; Hagl, S.; Werner, D.; Röhner, N.; Kögel, D.; Bazan, N. G.; Eckert, G. P. Omega-3 Polyunsaturated Fatty Acids Improve Mitochondrial Dysfunction in Brain Aging–Impact of Bcl-2 and NPD-1 like Metabolites. Prostaglandins Leukot. Essent. Fatty Acids 2015, 92, 23–31. https://doi.org/10.1016/j.plefa.2014.05.008.
(475) Sun, R.; Wang, X.; Liu, Y.; Xia, M. Dietary Supplementation with Fish Oil Alters the Expression Levels of Proteins Governing Mitochondrial Dynamics and Prevents High-Fat Diet-Induced Endothelial Dysfunction. Br. J. Nutr. 2014, 112 (2), 145–153. https://doi.org/10.1017/S0007114514000701.
(476) Lepretti, M.; Martucciello, S.; Burgos Aceves, M. A.; Putti, R.; Lionetti, L. Omega-3 Fatty Acids and Insulin Resistance: Focus on the Regulation of Mitochondria and Endoplasmic Reticulum Stress. Nutrients 2018, 10 (3). https://doi.org/10.3390/nu10030350.
(477) Aoun, M.; Feillet-Coudray, C.; Fouret, G.; Chabi, B.; Crouzier, D.; Ferreri, C.; Chatgilialoglu, C.; Wrutniak-Cabello, C.; Cristol, J. P.; Carbonneau, M.-A.; Coudray, C. Rat Liver Mitochondrial Membrane Characteristics and Mitochondrial Functions Are More Profoundly Altered by Dietary Lipid Quantity than by Dietary Lipid Quality: Effect of Different Nutritional Lipid Patterns. Br. J. Nutr. 2012, 107 (5), 647–659. https://doi.org/10.1017/S000711451100331X.
(478) Pliml, W.; von Arnim, T.; Stäblein, A.; Hofmann, H.; Zimmer, H. G.; Erdmann, E. Effects of Ribose on Exercise-Induced Ischaemia in Stable Coronary Artery Disease. Lancet 1992, 340 (8818), 507–510. https://doi.org/10.1016/0140-6736(92)91709-h.
(479) Hwang, P. S.; Machek, S. B.; Cardaci, T. D.; Wilburn, D. T.; Kim, C. S.; Suezaki, E. S.; Willoughby, D. S. Effects of Pyrroloquinoline Quinone (PQQ) Supplementation on Aerobic Exercise Performance and Indices of Mitochondrial Biogenesis in Untrained Men. J Am Coll Nutr 2019, 1–10. https://doi.org/10.1080/07315724.2019.1705203.
(480) Kumazawa, T.; Sato, K.; Seno, H.; Ishii, A.; Suzuki, O. Levels of Pyrroloquinoline Quinone in Various Foods. Biochem. J. 1995, 307 ( Pt 2), 331–333. https://doi.org/10.1042/bj3070331.